LOINC Prerelease Terms

DISCLAIMER

These codes are currently under development by the LOINC team, and are subject to change prior to inclusion in a future, public release. They are provided here for informational purposes only.

SPECIAL USE

Special Use codes are developed in response to an urgent or emergent situation. These codes are based on the most up to date information available at the time of their creation. They have undergone the normal QA terminology process. LOINC supports their use in the unique situation that resulted in their rapid creation. However, be aware that downstream users may not be ready to handle prerelease codes until they are published in an official release.

scroll/swipe to view more columns

Created On LOINC Long Common Name Special Use Component Prop Time System Scale Method Shortname
2023-10-23 103559-1 Rhinovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection Rhinovirus RNA PrThr Pt Nph Ord Non-probe.amp.tar Rhinovirus RNA Nph Ql NAA+non-probe
2023-09-22 103557-5 SARS-CoV-2 (COVID-19) Mpro gene mutation detected [Identifier] in Specimen by Molecular genetics method Nominal SARS coronavirus 2 Mpro gene mutation detected Prid Pt XXX Nom Molgen SARS-CoV-2 Mpro gene mut Spec
2024-02-05 104478-3 ITpA-Index Serum and CSF Treponema pallidum index RelRto Pt Ser+CSF Qn
2024-02-03 104476-7 Zika virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Zika virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104475-9 Zika virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Zika virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104473-4 Yersinia pseudotuberculosis 2 Ab [Presence] in Stool Yersinia pseudotuberculosis 2 Ab PrThr Pt Stool Ord
2024-02-03 104474-2 Yersinia pseudotuberculosis 3 Ab [Presence] in Stool Yersinia pseudotuberculosis 3 Ab PrThr Pt Stool Ord
2024-02-03 104472-6 Yersinia pseudotuberculosis 1 Ab [Presence] in Stool Yersinia pseudotuberculosis 1 Ab PrThr Pt Stool Ord
2024-02-03 104470-0 Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Yersinia pestis Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104469-2 Yersinia pestis IgG Ab [Titer] in Serum by Immunoassay --1st specimen Yersinia pestis Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104467-6 Yersinia enterocolitica O:8 Ab [Presence] in Stool Yersinia enterocolitica O:8 Ab PrThr Pt Stool Ord
2024-02-03 104468-4 Yersinia enterocolitica O:9 Ab [Presence] in Stool Yersinia enterocolitica O:9 Ab PrThr Pt Stool Ord
2024-02-03 104466-8 Yersinia enterocolitica O:5 Ab [Presence] in Stool Yersinia enterocolitica O:5 Ab PrThr Pt Stool Ord
2024-02-03 104464-3 Yersinia enterocolitica biotype [Presence] in Stool Yersinia enterocolitica biotype PrThr Pt Stool Ord
2024-02-03 104465-0 Yersinia enterocolitica O:3 Ab [Presence] in Stool Yersinia enterocolitica O:3 Ab PrThr Pt Stool Ord
2024-02-03 104463-5 Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Yellow fever virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104461-9 Yellow fever virus IgG Ab [Titer] in Serum by Immunoassay Yellow fever virus Ab.IgG Titr Pt Ser SemiQn IA
2024-02-03 104459-3 Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay Varicella zoster virus Ab.IgG PrThr Pt CSF Ord IA
2024-02-03 104456-9 Varicella zoster virus Ab.IgA index in Serum and CSF Varicella zoster virus Ab.IgA index ACnc Pt Ser+CSF Qn
2024-02-03 104457-7 Varicella zoster virus IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay Varicella zoster virus Ab.IgA PrThr Pt CSF Ord IA
2024-02-03 104453-6 Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --1st specimen Trichinella spiralis Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104454-4 Trichinella spiralis IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Trichinella spiralis Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104452-8 Toxoplasma gondii IgG Ab [Presence] in Serum by Immunoblot Toxoplasma gondii Ab.IgG PrThr Pt Ser Ord IB
2024-02-03 104450-2 Salmonella typhi DNA [Presence] in Isolate by NAA with probe detection Salmonella typhi DNA PrThr Pt Isolate Ord Probe.amp.tar
2024-02-03 104451-0 SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen SARS coronavirus 2 RNA PrThr Pt Respiratory System Specimen Ord
2024-02-03 104449-4 Salmonella paratyphi DNA [Presence] in Blood by NAA with probe detection Salmonella paratyphi DNA PrThr Pt Bld Ord Probe.amp.tar
2024-02-03 104448-6 Salmonella paratyphi [Identifier] in Isolate by Agglutination Salmonella paratyphi ID Pt Isolate Nom Aggl
2024-02-03 104446-0 Rubella virus IgM Ab index [Units/volume] in Serum and CSF Rubella virus Ab.IgM index ACnc Pt Ser+CSF Qn
2024-02-03 104447-8 Salmonella paratyphi DNA [Presence] in Isolate by NAA with probe detection Salmonella paratyphi DNA PrThr Pt Isolate Ord Probe.amp.tar
2024-02-03 104444-5 Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Rickettsia prowazekii Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104443-7 Rickettsia prowazekii IgG Ab [Titer] in Serum by Immunoassay --1st specimen Rickettsia prowazekii Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104440-3 Polio virus 3 Ab [Titer] in Serum by Immunoassay --2nd specimen Polio virus 3 Ab^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104439-5 Polio virus 3 Ab [Titer] in Serum by Immunoassay --1st specimen Polio virus 3 Ab^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104437-9 Polio virus 1 Ab [Titer] in Serum by Immunoassay --2nd specimen Polio virus 1 Ab^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104435-3 Norovirus genogroup II Ag [Presence] in Stool Norovirus genogroup II Ag PrThr Pt Stool Ord
2024-02-03 104436-1 Polio virus 1 Ab [Titer] in Serum by Immunoassay --1st specimen Polio virus 1 Ab^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104434-6 Norovirus Ag [Presence] in Specimen Norovirus Ag PrThr Pt XXX Ord
2024-02-03 104432-0 Mycobacterium leprae Ab. anti-PGL-1 Ab [Titer] in Serum Mycobacterium leprae anti-PGL-1 Ab Titr Pt Ser SemiQn
2024-02-03 104433-8 Mycobacterium leprae DNA [Presence] in Specimen by NAA with probe detection Mycobacterium leprae DNA PrThr Pt XXX Ord Probe.amp.tar
2024-02-03 104431-2 Mumps virus IgM Ab [Units/volume] in Serum and CSF Mumps virus Ab.IgM ACnc Pt Ser+CSF SemiQn
2024-02-03 104429-6 Measles virus IgM Ab [Ratio] in Serum by Immunoassay Measles virus Ab.IgM Ratio Pt Ser SemiQn IA
2024-02-03 104430-4 Middle East respiratory syndrome coronavirus (MERS-CoV) [Presence] in Specimen by Neutralization test Middle East respiratory syndrome coronavirus PrThr Pt XXX Ord Neut
2024-02-03 104428-8 Measles virus IgG Ab avidity [Ratio] in Serum by Immunoassay Measles virus Ab.IgG avidity Ratio Pt Ser SemiQn IA
2024-02-03 104427-0 Measles virus genotype [Identifier] in Specimen by Sequencing Measles virus genotype ID Pt XXX Nom Sequencing
2024-02-03 104425-4 Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --2nd specimen Leptospira sp Ab.IgM^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104424-7 Leptospira sp IgM Ab [Titer] in Serum by Immunoassay --1st specimen Leptospira sp Ab.IgM^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104422-1 Leptospira sp Ab [Titer] in Serum by Immunoassay --2nd specimen Leptospira sp Ab^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104421-3 Legionella sp Ag [Identifier] in Urine by Immunoassay Legionella sp Ag ID Pt Urine Nom IA
2024-02-03 104419-7 Legionella sp Ab [Titer] in Serum Qualitative by Immunoassay --1st specimen Legionella sp Ab^1st specimen Titr Pt Ser Ord IA
2024-02-03 104416-3 Lassa virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Lassa virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104417-1 Lassa virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Lassa virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104413-0 Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Hepatitis E virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104414-8 Hepatitis E virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Hepatitis E virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104412-2 Hepatitis A virus IgM Ab [Titer] in Serum Hepatitis A virus Ab.IgM Titr Pt Ser SemiQn
2024-02-03 104410-6 Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Hepatitis A virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104409-8 Hepatitis A virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Hepatitis A virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104406-4 Hantavirus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Hantavirus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104407-2 Hantavirus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Hantavirus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104405-6 Giardia lamblia trophozoites [Presence] in Stool by Microscopy Giardia lamblia trophozoites PrThr Pt Stool Ord Microscopy
2024-02-03 104404-9 Giardia lamblia cysts [Presence] in Stool by Microscopy Giardia lamblia cysts PrThr Pt Stool Ord Microscopy
2024-02-03 104402-3 Francisella tularensis Ab [Titer] in Serum by Immunoassay --2nd specimen Francisella tularensis Ab^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104400-7 European tick borne encephalitis virus RNA [Presence] in Tissue postmortem by NAA with probe detection European tick borne encephalitis virus RNA PrThr Pt Tissue.postmortem Ord Probe.amp.tar
2024-02-03 104401-5 Francisella tularensis Ab [Titer] in Serum by Immunoassay --1st specimen Francisella tularensis Ab^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104399-1 European tick borne encephalitis virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection European tick borne encephalitis virus RNA PrThr Pt CSF Ord Probe.amp.tar
2024-02-03 104398-3 European tick borne encephalitis virus IgM Ab [Titer] in Serum by Immunoassay European tick borne encephalitis virus Ab.IgM Titr Pt Ser SemiQn IA
2024-02-03 104397-5 European tick borne encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay European tick borne encephalitis virus Ab.IgM Titr Pt CSF SemiQn IA
2024-02-03 104395-9 European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen European tick borne encephalitis virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104393-4 European tick borne encephalitis virus IgA Ab index in Serum and CSF European tick borne encephalitis virus Ab.IgA index ACnc Pt Ser+CSF Qn
2024-02-03 104394-2 European tick borne encephalitis virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen European tick borne encephalitis virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104391-8 Echinococcus sp [Identifier] in Specimen Echinococcus sp Prid Pt XXX Doc
2024-02-03 104389-2 Ebola virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Ebola virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104390-0 Ebola virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Ebola virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104386-8 Dengue virus IgM Ab [Titer] in Serum by Immunoassay --1st specimen Dengue virus Ab.IgM^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104387-6 Dengue virus IgM Ab [Titer] in Serum by Immunoassay --2nd specimen Dengue virus Ab.IgM^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104383-5 Dengue virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Dengue virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104384-3 Dengue virus IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Dengue virus Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104380-1 Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --2nd specimen Coxiella burnetii Ab.IgM^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104381-9 Coxiella burnetii IgM Ab [Titer] in Serum by Immunoassay --1st specimen Coxiella burnetii Ab.IgM^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104377-7 Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --1st specimen Coxiella burnetii Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104378-5 Coxiella burnetii IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Coxiella burnetii Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104376-9 Diphtheria toxin DNA [Presence] in Specimen by NAA with probe detection Diphtheria toxin DNA PrThr Pt XXX Ord Probe.amp.tar
2024-02-03 104375-1 Corynebacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection Corynebacterium ulcerans DNA PrThr Pt XXX Ord Probe.amp.tar
2024-02-03 104373-6 Corynebacterium ulcerans [Presence] in Specimen by Organism specific culture Corynebacterium ulcerans PrThr Pt XXX Ord Organism specific culture
2024-02-03 104374-4 Corynebacterium ulcerans [Presence] in Upper respiratory specimen by Organism specific culture Corynebacterium ulcerans PrThr Pt Respiratory system specimen.upper Ord Organism specific culture
2024-02-03 104372-8 Corynebacterium pseudotuberculosis [Presence] in Upper respiratory specimen by Organism specific culture Corynebacterium pseudotuberculosis PrThr Pt Respiratory system specimen.upper Ord Organism specific culture
2024-02-03 104370-2 Clostridium butyricum [Presence] in Specimen Clostridium butyricum PrThr Pt XXX Ord
2024-02-03 104371-0 Corynebacterium pseudotuberculosis [Presence] in Specimen by Organism specific culture Corynebacterium pseudotuberculosis PrThr Pt XXX Ord Organism specific culture
2024-02-03 104369-4 Clostridium baratii [Presence] in Specimen Clostridium baratii PrThr Pt XXX Ord
2024-02-03 104368-6 Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --2nd specimen Chlamydophila psittaci Ab^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104366-0 Chlamydophila psittaci Ab [Titer] in Serum by Immunoassay --1st specimen Chlamydophila psittaci Ab^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104364-5 Chikungunya virus IgG Ab [Titer] in Serum by Immunoassay --1st specimen Chikungunya virus Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104362-9 Brucella sp DNA [Identifier] in Specimen by NAA with non-probe detection Brucella sp DNA ID Pt XXX Nom Non-probe.amp.tar
2024-02-03 104360-3 Brucella sp Ab [Titer] in Serum by Immunoassay --1st specimen Brucella sp Ab^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104361-1 Brucella sp Ab [Titer] in Serum by Immunoassay --2nd specimen Brucella sp Ab^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104359-5 Brucella melitensis DNA [Presence] in Specimen by NAA with non-probe detection Brucella melitensis DNA PrThr Pt XXX Ord Non-probe.amp.tar
2024-02-03 104358-7 Spirochete [Identifier] in Specimen by Microscopy Spirochete Prid Pt XXX Nom Microscopy
2024-02-03 104357-9 Borrelia recurrentis DNA [Presence] in Specimen by Sequencing Borrelia recurrentis DNA PrThr Pt XXX Ord Sequencing
2024-02-03 104356-1 Borrelia recurrentis DNA [Presence] in Specimen by NAA with probe detection Borrelia recurrentis DNA PrThr Pt XXX Ord Probe.amp.tar
2024-02-03 104355-3 Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by Sequencing Borrelia recurrentis DNA PrThr Pt CSF Ord Sequencing
2024-02-03 104354-6 Borrelia recurrentis DNA [Presence] in Cerebral spinal fluid by NAA with probe detection Borrelia recurrentis DNA PrThr Pt CSF Ord Probe.amp.tar
2024-02-03 104353-8 Borrelia recurrentis DNA [Presence] in Blood by Sequencing Borrelia recurrentis DNA PrThr Pt Bld Ord Sequencing
2024-02-03 104352-0 Borrelia recurrentis DNA [Presence] in Blood by NAA with probe detection Borrelia recurrentis DNA PrThr Pt Bld Ord Probe.amp.tar
2024-02-03 104351-2 Borrelia recurrentis [Presence] in Specimen by Organism specific culture Borrelia recurrentis PrThr Pt XXX Ord Organism specific culture
2024-02-03 104350-4 Borrelia recurrentis [Presence] in Specimen by Microscopy Borrelia recurrentis PrThr Pt XXX Ord Microscopy
2024-02-03 104349-6 Borrelia recurrentis [Presence] in Blood by Organism specific culture Borrelia recurrentis PrThr Pt Bld Ord Organism specific culture
2024-02-03 104348-8 Borrelia recurrentis [Presence] in Blood by Microscopy Borrelia recurrentis PrThr Pt Bld Ord Microscopy
2024-02-03 104347-0 Borrelia recurrentis [Presence] in Cerebral spinal fluid by Organism specific culture Borrelia recurrentis PrThr Pt CSF Ord Organism specific culture
2024-02-03 104346-2 Borna disease virus Ag [Presence] in Specimen by Immune stain Borna disease virus Ag PrThr Pt XXX Ord Immune stain
2024-02-03 104345-4 Borna disease virus Ag [Presence] in Brain tissue by Immune stain Borna disease virus Ag PrThr Pt Brain tissue Ord Immune stain
2024-02-03 104344-7 Borna disease virus RNA [Presence] in Specimen by Sequencing Borna disease virus RNA PrThr Pt XXX Ord Sequencing
2024-02-03 104343-9 Borna disease virus [Presence] in Specimen by Organism specific culture Borna disease virus PrThr Pt XXX Ord Organism specific culture
2024-02-03 104342-1 Borna disease virus RNA [Presence] in Specimen by NAA with probe detection Borna disease virus RNA PrThr Pt XXX Ord Probe.amp.tar
2024-02-03 104341-3 Borna disease virus [Presence] in Specimen Borna disease virus PrThr Pt XXX Ord
2024-02-03 104340-5 Borna disease virus RNA [Presence] in Cerebral spinal fluid by NAA with probe detection Borna disease virus RNA PrThr Pt CSF Ord Probe.amp.tar
2024-02-03 104339-7 Borna disease virus RNA [Presence] in Brain tissue by Sequencing Borna disease virus RNA PrThr Pt Brain tissue Ord Sequencing
2024-02-03 104338-9 Borna disease virus RNA [Presence] in Brain tissue by Probe Borna disease virus RNA PrThr Pt Brain tissue Ord Probe
2024-02-03 104337-1 Borna disease virus RNA [Presence] in Brain tissue by NAA with probe detection Borna disease virus RNA PrThr Pt Brain tissue Ord Probe.amp.tar
2024-02-03 104335-5 Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --2nd specimen Bordetella pertussis.pertussis toxin Ab.IgG^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104334-8 Bordetella pertussis.pertussis toxin IgG Ab [Titer] in Serum by Immunoassay --1st specimen Bordetella pertussis.pertussis toxin Ab.IgG^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104332-2 Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --2nd specimen Bordetella pertussis Ab.IgA^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104331-4 Bordetella pertussis IgA Ab [Titer] in Serum by Immunoassay --1st specimen Bordetella pertussis Ab.IgA^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104330-6 Bacillus anthracis protective antigen Ab [Presence] in Serum by Immunoassay Bacillus anthracis protective antigen Ab PrThr Pt Ser Ord IA
2024-02-03 104328-0 Bacillus anthracis Ab [Titer] in Serum by Immunoassay --2nd specimen Bacillus anthracis Ab^2nd specimen Titr Pt Ser SemiQn IA
2024-02-03 104327-2 Bacillus anthracis Ab [Titer] in Serum by Immunoassay --1st specimen Bacillus anthracis Ab^1st specimen Titr Pt Ser SemiQn IA
2024-02-03 104326-4 Adenovirus sp identified [Type] in Specimen by Sequencing Adenovirus sp identified Type Pt XXX Nom Sequencing
2024-02-03 104324-9 Acinetobacter sp identified [Type] in Specimen by Sequencing Acinetobacter sp identified Type Pt XXX Nom Sequencing
2024-02-02 104323-1 IDH1 and IDH2 gene full mutation analysis in Blood or Tissue by Molecular genetics method IDH1 & IDH2 gene full mutation analysis Find Pt Bld/Tiss Doc Molgen
2024-01-31 104322-3 Lambda lymphocytes/100 lymphocytes in Bone marrow Lymphocytes.lambda/100 lymphocytes NFr Pt Bone mar Qn
2024-01-31 104321-5 CXCR4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal CXCR4 gene targeted mutation analysis Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104320-7 Burst forming unit erythroid [#/mass] in Blood Burst forming unit erythroid NCnt Pt Bld Qn
2024-01-31 104319-9 Burst forming unit erythroid [#/volume] in Blood by Visual count Burst forming unit erythroid NCnc Pt Bld Qn VC
2024-01-31 104318-1 Common myeloid progenitor cell [#/mass] in Blood Common myeloid progenitor cell NCnt Pt Bld Qn
2024-01-31 104317-3 Common myeloid progenitor cell [#/volume] in Blood by Visual count Common myeloid progenitor cell NCnc Pt Bld Qn VC
2024-01-31 104316-5 N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma N-Desethyl Sunitinib MCnc Pt Ser/Plas Qn
2024-01-31 104315-7 Sunitinib [Mass/volume] in Serum or Plasma Sunitinib MCnc Pt Ser/Plas Qn
2024-01-31 104314-0 Lenvatinib [Mass/volume] in Serum or Plasma Lenvatinib MCnc Pt Ser/Plas Qn
2024-01-31 104313-2 Niraparib [Mass/volume] in Serum or Plasma Niraparib MCnc Pt Ser/Plas Qn
2024-01-31 104312-4 Rucaparib [Mass/volume] in Serum or Plasma Rucaparib MCnc Pt Ser/Plas Qn
2024-01-31 104311-6 Olaparib [Mass/volume] in Serum or Plasma Olaparib MCnc Pt Ser/Plas Qn
2024-01-31 104310-8 Abemaciclib [Mass/volume] in Serum or Plasma Abemaciclib MCnc Pt Ser/Plas Qn
2024-01-31 104309-0 Ribociclib [Mass/volume] in Serum or Plasma Ribociclib MCnc Pt Ser/Plas Qn
2024-01-31 104308-2 Palbociclib [Mass/volume] in Serum or Plasma Palbociclib MCnc Pt Ser/Plas Qn
2024-01-31 104307-4 Letrozole [Mass/volume] in Serum or Plasma Letrozole MCnc Pt Ser/Plas Qn
2024-01-31 104306-6 Sorafenib N-Oxide [Mass/volume] in Serum or Plasma Sorafenib N-Oxide MCnc Pt Ser/Plas Qn
2024-01-31 104305-8 Regorafenib N-oxide [Mass/volume] in Serum or Plasma Regorafenib N-oxide MCnc Pt Ser/Plas Qn
2024-01-31 104304-1 Regorafenib [Mass/volume] in Serum or Plasma Regorafenib MCnc Pt Ser/Plas Qn
2024-01-31 104303-3 N-Desmethyl imatinib [Mass/volume] in Serum or Plasma N-Desmethyl imatinib MCnc Pt Ser/Plas Qn
2024-01-31 104302-5 UGT1A9 gene.c.-275T>A [Presence] in Blood or Tissue by Molecular genetics method UGT1A9 gene.c.-275T>A PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104301-7 UGT1A9 gene.c.-2152C>T [Presence] in Blood or Tissue by Molecular genetics method UGT1A9 gene.c.-2152C>T PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104299-3 UGT1A9 gene.1b-118(dT)9>10 [Presence] in Blood or Tissue by Molecular genetics method UGT1A9 gene.1b-118(dT)9>10 PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104300-9 UGT1A9 gene.p.M33T [Presence] in Blood or Tissue by Molecular genetics method UGT1A9 gene.p.M33T PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104298-5 CYP3A4 gene.c.IVS10+12G>A [Presence] in Blood or Tissue by Molecular genetics method CYP3A4 gene.c.IVS10+12G>A PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104297-7 CYP3A4 gene c.6C>T [Presence] in Blood or Tissue by Molecular genetics method CYP3A4 gene.c.6C>T PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104296-9 DPYD gene.c.1905+1G>A [Presence] in Blood or Tissue by Molecular genetics method DPYD gene.c.1905+1G>A PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104295-1 ESR1 gene mutation [Identifier] in Blood or Tissue by Molecular genetics method Nominal ESR1 gene mutation Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104294-4 CDH1 gene rearrangements [Interpretation] in Blood or Tissue by Molecular genetics method Narrative CDH1 gene rearrangements Imp Pt Bld/Tiss Nar Molgen
2024-01-31 104293-6 PDGFRA gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal PDGFRA gene targeted mutation analysis Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104292-8 PDGFRA gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal PDGFRA gene mutations tested for Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104291-0 KIT gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal KIT gene mutations tested for Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104290-2 ROS proto-oncogene 1 mutations tested for in Blood or Tissue by Molecular genetics method Nominal ROS1 gene mutations tested for Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104289-4 Chromosome 5 and 9 and 15 aneuploidy in Bone marrow by FISH Chromosome 5 & 9 & 15 aneuploidy Find Pt Bone mar Doc FISH
2024-01-31 104288-6 HLA-B gene.g.31431780T>G [Presence] in Blood or Tissue by Molecular genetics method HLA-B gene.g.31431780T>G PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104287-8 SLCO1B1 gene.c.521T>C [Presence] in Blood or Tissue by Molecular genetics method SLCO1B1 gene.c.521T>C PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104286-0 UGT1A1 gene.p.P229Q [Presence] in Blood or Tissue by Molecular genetics method UGT1A1 gene.p.P229Q PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104285-2 UGT1A1 gene.p.G71R [Presence] in Blood or Tissue by Molecular genetics method UGT1A1 gene.p.G71R PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104284-5 DPYD gene.c.1679T>G [Presence] in Blood or Tissue by Molecular genetics method DPYD gene.c.1679T>G PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104283-7 DPYD gene.c.2846A>T [Presence] in Blood or Tissue by Molecular genetics method DPYD gene.c.2846A>T PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104282-9 ABCB1 gene.c.2677G>T [Presence] in Blood or Tissue by Molecular genetics method ABCB1 gene.c.2677G>T PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104281-1 ABCB1 gene.c.1236C>T [Presence] in Blood or Tissue by Molecular genetics method ABCB1 gene.c.1236C>T PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104280-3 ABCG2 gene.p.Q141K [Presence] in Blood or Tissue by Molecular genetics method ABCG2 gene.p.Q141K PrThr Pt Bld/Tiss Ord Molgen
2024-01-31 104279-5 ERBB2 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal ERBB2 gene mutations tested for Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104278-7 BRAF gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal BRAF gene mutations tested for Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104277-9 MET gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal MET gene mutations tested for Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104276-1 ALK gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal ALK gene mutations tested for Prid Pt Bld/Tiss Nom Molgen
2024-01-31 104275-3 Hematopoietic progenitor cells/Cells.total in Blood by Automated count Hematopoietic progenitor cells/cells.total NFr Pt Bld Qn Automated count
2024-01-31 104274-6 Abnormal clonal sequences [Nucleotide sequence] in Specimen by Molecular genetics method Nominal Clonal sequences.abnormal Seq Pt XXX Nom Molgen
2024-01-31 104273-8 Clonal cells rearrangements/Cells counted in Specimen by Molecular genetics method Cells.clonal rearrangements/Cells counted NFr Pt XXX Qn Molgen
2024-01-31 104272-0 IgH and IgK gene rearrangement status [Identifier] in Specimen by Molecular genetics method Nominal IgH & IgK gene rearrangement status Prid Pt XXX Nom Molgen
2024-01-31 104271-2 Primer set [Identifier] in Specimen by Molecular genetics method Primer set ID Pt XXX Nom Molgen
2024-01-31 104270-4 J gene rearrangement [Identifier] in Specimen by Molecular genetics method Nominal J gene rearrangement Prid Pt XXX Nom Molgen
2024-01-31 104269-6 V gene rearrangement [Identifier] in Specimen by Molecular genetics method Nominal V gene rearrangement Prid Pt XXX Nom Molgen
2024-01-31 104268-8 UBA1 gene mutation in Specimen by Molecular genetics method UBA1 gene mutation Find Pt XXX Doc Molgen
2024-01-31 104267-0 Protein.glycosylated [Presence] in Serum or Plasma Protein.glycosylated PrThr Pt Ser/Plas Ord
2024-01-31 104266-2 Immunoglobulins and heavy-light chain panel - Serum or Plasma Immunoglobulins and heavy-light chain panel - Pt Ser/Plas -
2024-01-31 104265-4 Ethanol cutoff [Volume Fraction] in Exhaled gas Ethanol cutoff VFr Pt Exhl gas SemiQn
2024-01-31 104264-7 Galactosylceramidase [Enzymatic activity/volume] in Cerebral spinal fluid by LC/MS/MS Galactosylceramidase CCnc Pt CSF Qn LC/MS/MS
2024-01-31 104263-9 Galactosylceramidase [Enzymatic activity/volume] in Serum by LC/MS/MS Galactosylceramidase CCnc Pt Ser Qn LC/MS/MS
2024-01-31 104262-1 Diagnostic peripheral vascular disease study Heart Diagnostic peripheral vascular disease study Type Pt Heart Nom
2024-01-31 104260-5 Hepatitis A virus cellular receptor 1 [Ratio] in Urine by Calculation Hepatitis A virus cellular receptor 1 Ratio Pt Urine Qn Calculation
2024-01-31 104261-3 Eosinophil derived neurotoxin [Mass/volume] in Serum by Immunoassay Eosinophil derived neurotoxin MCnc Pt Ser Qn IA
2024-01-31 104259-7 Fibroblast growth factor 23 [Presence] in Tissue by FISH Fibroblast growth factor 23 PrThr Pt Tissue Ord FISH
2024-01-31 104258-9 Left ventricular Ejection fraction - lower limit by US.2D.A2C+Estimated Ejection fraction - lower limit VFr Pt Heart.ventricle.left Qn US.2D.A2C+Estimated
2024-01-31 104256-3 Left ventricular Ejection fraction by US.3D.A4C+Estimated Ejection fraction VFr Pt Heart.ventricle.left Qn US.3D.A4C+Estimated
2024-01-31 104255-5 Left ventricular Ejection fraction by US.3D.A3C+Estimated Ejection fraction VFr Pt Heart.ventricle.left Qn US.3D.A3C+Estimated
2024-01-31 104254-8 Left ventricular Ejection fraction by US.3D.A2C+Estimated Ejection fraction VFr Pt Heart.ventricle.left Qn US.3D.A2C+Estimated
2024-01-31 104253-0 Left ventricular Ejection fraction by US.2D.A4C Estimated Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A4C+Estimated
2024-01-31 104252-2 Left ventricular Ejection fraction by US.2D.A3C+Estimated Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A3C+Estimated
2024-01-31 104251-4 Left ventricular Ejection fraction by US.2D.A2C+Estimated Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A2C+Estimated
2024-01-31 104250-6 Platelet aggregation collagen induced in Platelet rich plasma --2 ug/mL Platelet aggregation.collagen induced^2 ug/mL RelACnc Pt PRP Qn
2024-01-31 104249-8 Platelet aggregation ADP induced ATP secretion in Blood --2 umol/L Platelet aggregation.adenosine diphosphate induced ATP secretion^2 umol/L RelACnc Pt Bld Qn
2024-01-31 104248-0 Pepsinogen I/Pepsinogen II [Mass Ratio] in Serum Pepsinogen I/Pepsinogen II MRto Pt Ser Qn
2024-01-31 104247-2 Left ventricular Ejection fraction - lower limit by US.3D.A4C+Estimated Ejection fraction - lower limit VFr Pt Heart.ventricle.left Qn US.3D.A4C+Estimated
2024-01-31 104246-4 Left ventricular Ejection fraction - lower limit by US.3D.A3C+Estimated Ejection fraction - lower limit VFr Pt Heart.ventricle.left Qn US.3D.A3C+Estimated
2024-01-31 104245-6 Left ventricular Ejection fraction - lower limit by US.3D.A2C+Estimated Ejection fraction - lower limit VFr Pt Heart.ventricle.left Qn US.3D.A2C+Estimated
2024-01-31 104244-9 Left ventricular Ejection fraction - lower limit by US.2D.A4C+Estimated Ejection fraction - lower limit VFr Pt Heart.ventricle.left Qn US.2D.A4C+Estimated
2024-01-31 104243-1 Left ventricular Ejection fraction - lower limit by US.2D.A3C+Estimated Ejection fraction - lower limit VFr Pt Heart.ventricle.left Qn US.2D.A3C+Estimated
2024-01-31 104242-3 T cell lymphoma multigene analysis in Blood or Tissue by Molecular genetics method T cell lymphoma multigene analysis Find Pt Bld/Tiss Doc Molgen
2024-01-31 104241-5 Plasma cell myeloma multigene analysis in Bone marrow by Molecular genetics method Plasma cell myeloma multigene analysis Find Pt Bone marrow Doc Molgen
2024-01-31 104240-7 Histiocytic neoplasm multigene analysis in Blood or Tissue by Molecular genetics method Histiocytic neoplasm multigene analysis Find Pt Bld/Tiss Doc Molgen
2024-01-31 104239-9 B cell non hodgkin Lymphoma multigene analysis in Blood or Tissue by Molecular genetics method B cell non hodgkin Lymphoma multigene analysis Find Pt Bld/Tiss Doc Molgen
2024-01-31 104238-1 Chronic and low grade B cell lymphoid neoplasm multigene analysis in Blood or Tissue by Molecular genetics method Chronic and low grade B cell lymphoid neoplasm multigene analysis Find Pt Bld/Tiss Doc Molgen
2024-01-31 104237-3 Zopiclone [Mass/volume] in Urine by Confirmatory method Zopiclone MCnc Pt Urine Qn Confirm
2024-01-31 104236-5 3-fluorophenmetrazine [Mass/volume] in Urine by Confirmatory method 3-fluorophenmetrazine MCnc Pt Urine Qn Confirm
2024-01-31 104235-7 Dibutylone [Mass/volume] in Urine by Confirmatory method Dibutylone MCnc Pt Urine Qn Confirm
2024-01-31 104234-0 Atomoxetine [Mass/volume] in Urine by Confirmatory method Atomoxetine MCnc Pt Urine Qn Confirm
2024-01-31 104233-2 Norcocaine [Mass/volume] in Urine by Confirmatory method Norcocaine MCnc Pt Urine Qn Confirm
2024-01-31 104232-4 Naproxen [Mass/volume] in Urine by Confirmatory method Naproxen MCnc Pt Urine Qn Confirm
2024-01-31 104231-6 N-Ethylpentylone [Mass/volume] in Urine by Confirmatory method N-Ethylpentylone MCnc Pt Urine Qn Confirm
2024-01-31 104229-0 Carfentanil [Mass/volume] in Urine by Confirmatory method Carfentanil MCnc Pt Urine Qn Confirm
2024-01-31 104230-8 MDMB-Fubinaca [Mass/volume] in Urine by Confirmatory method MDMB-Fubinaca MCnc Pt Urine Qn Confirm
2024-01-31 104228-2 Alpha-Pyrrolidinoisohexanophenone [Mass/volume] in Urine by Confirmatory method Alpha-Pyrrolidinoisohexanophenone MCnc Pt Urine Qn Confirm
2024-01-31 104227-4 Rizatriptan [Mass/volume] in Urine by Confirmatory method Rizatriptan MCnc Pt Urine Qn Confirm
2024-01-31 104226-6 Duration description of condition episode - Reported Duration description of condition episode Find Pt ^Patient Ord Reported
2024-01-31 104225-8 HLA-DPB1+DPA1 Typing panel - Blood or Tissue HLA-DPB1+DPA1 Typing panel - Pt Bld/Tiss -
2024-01-31 104224-1 HLA-DPB1+DPA1 Typing panel - Blood or Tissue from Donor HLA-DPB1+DPA1 Typing panel - Pt Bld/Tiss^Donor -
2024-01-31 104223-3 Spermatozoa.progressive.slow+rapid/100 spermatozoa in Urine --post ejaculation Spermatozoa.progressive.slow+rapid/100 spermatozoa^post ejaculation NFr Pt Urine Qn
2024-01-31 104222-5 Spermatozoa.progressive.slow/100 spermatozoa in Urine --post ejaculation Spermatozoa.progressive.slow/100 spermatozoa^post ejaculation NFr Pt Urine Qn
2024-01-31 104220-9 Spermatozoa Viable/100 spermatozoa in Urine --post ejaculation Spermatozoa.viable/100 spermatozoa^post ejaculation NFr Pt Urine Qn
2024-01-31 104221-7 Spermatozoa.progressive.rapid/100 spermatozoa in Urine --post ejaculation Spermatozoa.progressive.rapid/100 spermatozoa^post ejaculation NFr Pt Urine Qn
2024-01-31 104219-1 Spermatozoa Immotile/100 spermatozoa in Urine --post ejaculation Spermatozoa.immotile/100 spermatozoa^post ejaculation NFr Pt Urine Qn
2024-01-31 104218-3 Spermatozoa Nonprogressive/100 spermatozoa in Urine --post ejaculation Spermatozoa.nonprogressive/100 spermatozoa^post ejaculation NFr Pt Urine Qn
2024-01-31 104216-7 MG stereo Breast - right Views post radioactive seed localization Views^post radioactive seed localization Find Pt Breast.right Doc MG.stereotactic
2024-01-31 104215-9 MG stereo Breast - left Views post radioactive seed localization Views^post radioactive seed localization Find Pt Breast.left Doc MG.stereotactic
2024-01-31 104214-2 Views screening for diabetic retinopathy of Right eye Views screening for diabetic retinopathy Find Pt Eye.right Doc {Imaging modality}
2024-01-31 104213-4 Views screening for diabetic retinopathy of Left eye Views screening for diabetic retinopathy Find Pt Eye.left Doc {Imaging modality}
2024-01-31 104212-6 Views screening for diabetic retinopathy of Eyes Views screening for diabetic retinopathy Find Pt Eyes Doc {Imaging modality}
2024-01-31 104211-8 Heart Multisection transesophageal for congenital disease Document by US --W agitated saline IV Multisection transesophageal for congenital disease^W agitated saline IV Find Pt Chest>Heart Doc US
2024-01-31 104210-0 Diagnostic multisection transesophageal and cardioversion panel Heart Diagnostic multisection transesophageal & cardioversion panel - Pt Heart -
2024-01-31 104208-4 Medication list for public health AndOr CDC reporting [Identifier] Episode Pharmacy Medication list for public health &or CDC reporting ID Episode Pharmacy Nom
2024-01-31 104209-2 Transfer medication list [Identifier] Episode Pharmacy Transfer medication list ID Episode Pharmacy Nom
2024-01-31 104207-6 Medication administration list [Identifier] Episode Pharmacy Medication administration list ID Episode Pharmacy Nom
2024-01-31 104205-0 Patient generated medication list [Identifier] Episode Pharmacy Patient generated medication list ID Episode Pharmacy Nom
2024-01-31 104206-8 Private medication list [Identifier] Episode Pharmacy Private medication list ID Episode Pharmacy Nom
2024-01-31 104204-3 Discharged medication list [Identifier] Episode Pharmacy Discharged medication list ID Episode Pharmacy Nom
2024-01-31 104203-5 Reconciled medication list [Identifier] Episode Pharmacy Reconciled medication list ID Episode Pharmacy Nom
2024-01-31 104202-7 Active medication list [Identifier] Episode Pharmacy Active medication list ID Episode Pharmacy Nom
2024-01-31 104201-9 Eszopiclone and Zopiclone [Mass/volume] in Urine by LC/MS/MS Eszopiclone+Zopiclone MCnc Pt Urine Qn LC/MS/MS
2024-01-31 104200-1 CRLF2 gene rearrangements in Blood or Marrow by FISH CRLF2 gene rearrangements Find Pt Bld/Bone mar Doc FISH
2024-01-31 104199-5 Immunoglobulin kappa light chain gene 2p11.2 rearrangement in Specimen by FISH Immunoglobulin kappa light chain gene 2p11.2 rearrangement Find Pt XXX Doc FISH
2024-01-31 104198-7 Immunoglobulin lambda light chain gene 22q11.22 rearrangement in Specimen by FISH Immunoglobulin lambda light chain gene 22q11.22 rearrangement Find Pt XXX Doc FISH
2024-01-31 104197-9 Fetal Pelvis for pregnancy in first trimester US Multisection for pregnancy+first trimester Find Pt Pelvis+^Fetus Nom US
2024-01-31 104196-1 Creatine/Creatinine [Molar ratio] in DBS Creatine/Creatinine SRto Pt Bld.dot Qn
2024-01-31 104195-3 Guanidinoacetate/Creatinine [Molar ratio] in DBS Guanidinoacetate/Creatinine SRto Pt Bld.dot Qn
2024-01-31 104194-6 Creatine [Moles/volume] in DBS Creatine SCnc Pt Bld.dot Qn
2024-01-31 104193-8 Guanidinoacetate methyltransferase deficiency comment [Text] in DBS Narrative Guanidinoacetate methyltransferase deficiency comment Txt Pt Bld.dot Nar
2024-01-31 104192-0 Guanidinoacetate methyltransferase deficiency newborn screen interpretation Guanidinoacetate methyltransferase deficiency Imp Pt Bld.dot Nom
2024-01-31 104191-2 Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel - Pt Bld.dot -
2024-01-31 104190-4 Mucopolysaccharidosis type II comment [Text] in DBS Narrative Mucopolysaccharidosis type II comment Txt Pt Bld.dot Nar
2024-01-31 104189-6 Mucopolysaccharidosis type II newborn screen interpretation newborn screen interpretation Mucopolysaccharidosis type II newborn screen interpretation Imp Pt Bld.dot Nom
2024-01-31 104188-8 Mucopolysaccharidosis type II newborn screening panel Mucopolysaccharidosis type II newborn screening panel - Pt Bld.dot -
2024-01-31 104187-0 Disease onset to death interval duration Disease onset to death interval Time Pt ^Patient Qn
2024-01-31 104186-2 Fetal Reason for death Reason for death Find Pt ^Fetus Nom
2024-01-31 104185-4 Fetal Secondary cause of death Secondary cause of death Find Pt ^Fetus Nom
2024-01-31 104184-7 Maternal condition that affected the fetus Mother Maternal condition that affected the fetus Find Pt ^Mother Nom
2024-01-31 104183-9 Adenovirus DNA [Presence] in Conjunctival specimen by NAA with probe detection Adenovirus DNA PrThr Pt Cnjt Ord Probe.amp.tar
2024-01-31 104182-1 Clostridium tetani toxin [Presence] in Serum or Plasma by Immunoassay Clostridium tetani toxin PrThr Pt Ser/Plas Ord IA
2024-01-31 104181-3 Clostridium tetani toxin [Presence] in Serum or Plasma by Mouse bioassay Clostridium tetani toxin PrThr Pt Ser/Plas Ord Mouse bioassay
2024-01-31 104180-5 Clostridium tetani toxin [Presence] in Serum or Plasma by Endopeptidase Assay Clostridium tetani toxin PrThr Pt Ser/Plas Ord Endopeptidase Assay
2024-01-31 104179-7 Clostridium tetani toxin [Presence] in Specimen by Endopeptidase Assay Clostridium tetani toxin PrThr Pt XXX Ord Endopeptidase Assay
2024-01-31 104178-9 Clostridium tetani toxin [Presence] in Specimen by Immunoassay Clostridium tetani toxin PrThr Pt XXX Ord IA
2024-01-31 104176-3 Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with probe detection Clostridium tetani toxin TeNT gene PrThr Pt XXX Ord Probe.amp.tar
2024-01-31 104177-1 Clostridium tetani toxin [Presence] in Specimen by Mouse bioassay neutralization Clostridium tetani toxin PrThr Pt XXX Ord Mouse bioassay.neutralization
2024-01-31 104175-5 Clostridium tetani toxin TeNT gene [Presence] in Specimen by NAA with non-probe detection Clostridium tetani toxin TeNT gene PrThr Pt XXX Ord Non-probe.amp.tar
2024-01-31 104174-8 DPYD gene.c.1679T>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal DPYD gene.c.1679T>G Geno Pt Bld/Tiss Nom Molgen
2024-01-31 104173-0 DPYD gene.c.1905+1G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal DPYD gene.c.1905+1G>A Geno Pt Bld/Tiss Nom Molgen
2024-01-31 104172-2 DPYD gene.c.1236G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal DPYD gene.c.1236G>A Geno Pt Bld/Tiss Nom Molgen
2024-01-31 104171-4 DPYD gene.c.2846A>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal DPYD gene.c.2846A>T Geno Pt Bld/Tiss Nom Molgen
2024-01-31 104170-6 Human papilloma virus 31+33+52+58 DNA [Presence] in Cervix by NAA with probe detection Human papilloma virus 31+33+52+58 DNA PrThr Pt Cvx Ord Probe.amp.tar
2024-01-31 104169-8 D13S319 deletion in Bone marrow by FISH D13S319 deletion Find Pt Bone marrow Doc FISH
2024-01-31 104168-0 TCL-1A gene rearrangements in Bone marrow by FISH TCL-1A gene rearrangements Find Pt Bone marrow Doc FISH
2024-01-31 104167-2 TRCA+TCRD gene rearrangements in Bone marrow by FISH TRCA+TCRD gene rearrangements Find Pt Bone marrow Doc FISH
2024-01-31 104166-4 Apolipoprotein E phenotype [Identifier] in Plasma by LC/MS/MS Apolipoprotein E phenotype Prid Pt Plas Nom LC/MS/MS
2024-01-30 104165-6 Aortic valve Orifice area/Body surface area [Area/Area] by US 2D Orifice area/Body surface area ArArea Pt Aortic valve Qn US.2D
2024-01-30 104164-9 Pulmonary artery Pressure by US.doppler Pressure Pres Pt Pulmonary artery Qn US.doppler
2024-01-30 104163-1 Left ventricular End-systolic volume/Body surface area [Volume/Area] by US.3D.A4C+Calculated by biplane area-length method End-systolic volume/Body surface area ArVol Pt Heart.ventricle.left Qn US.3D.A4C+Calculated by biplane area-length method
2024-01-30 104162-3 Left ventricular End-systolic volume/Body surface area [Volume/Area] by US.3D.A2C+Calculated by biplane area-length method End-systolic volume/Body surface area ArVol Pt Heart.ventricle.left Qn US.3D.A2C+Calculated by biplane area-length method
2024-01-30 104161-5 Left ventricular End-systolic volume/Body surface area [Volume/Area] by US.2D.A4C+Calculated by biplane area-length method End-systolic volume/Body surface area ArVol Pt Heart.ventricle.left Qn US.2D.A4C+Calculated by biplane area-length method
2024-01-30 104160-7 Left ventricular End-systolic volume (by US.2D.A2C+Calculated by biplane area-length method)/Body surface area End-systolic volume/Body surface area ArVol Pt Heart.ventricle.left Qn US.2D.A2C+Calculated by biplane area-length method
2024-01-30 104159-9 Left ventricular Maximum longitudinal strain by US.2D+Calculated by average triplane method Longitudinal strain.max LenRto Pt Heart.ventricle.left Qn US.2D+Calculated by triplane method
2024-01-30 104158-1 Associated precondition - Reported Associated precondition Find Pt ^Patient Ord Reported
2024-01-30 104157-3 Left ventricular Ejection fraction - upper limit by US.2D.A4C+Estimated Ejection fraction - upper limit VFr Pt Heart.ventricle.left Qn US.2D.A4C+Estimated
2024-01-30 104156-5 Condition frequency - Reported Condition frequency NRat Pt ^Patient Ord Reported
2024-01-30 104155-7 Left ventricular Ejection fraction - upper limit by US.3D.A2C+Estimated Ejection fraction - upper limit VFr Pt Heart.ventricle.left Qn US.3D.A2C+Estimated
2024-01-30 104154-0 Left ventricular Ejection fraction by US.3D.A4C+Calculated by biplane method Ejection fraction VFr Pt Heart.ventricle.left Qn US.3D.A4C+Calculated by biplane method
2024-01-30 104153-2 Left ventricular Ejection fraction by US.3D.A3C+Calculated by biplane method Ejection fraction VFr Pt Heart.ventricle.left Qn US.3D.A3C+Calculated by biplane method
2024-01-30 104152-4 Left ventricular Ejection fraction by US.3D.A2C+Calculated by biplane method Ejection fraction VFr Pt Heart.ventricle.left Qn US.3D.A2C+Calculated by biplane method
2024-01-30 104151-6 Left ventricular Ejection fraction by US.2D.A4C+Calculed by biplane method Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A4C+Calculed by biplane method
2024-01-30 104150-8 Left ventricular Ejection fraction by US.2D.A3C+Calculated by biplane method Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A3C+Calculated by biplane method
2024-01-30 104149-0 Left ventricular Ejection fraction by US.2D.A2C+Calculated by biplane method Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A2C+Calculated by biplane method
2024-01-30 104148-2 Left ventricular Ejection fraction - upper limit by US.3D.A4C+Estimated Ejection fraction - upper limit VFr Pt Heart.ventricle.left Qn US.3D.A4C+Estimated
2024-01-30 104147-4 Left ventricular Ejection fraction - upper limit by US.3D.A3C+Estimated Ejection fraction - upper limit VFr Pt Heart.ventricle.left Qn US.3D.A3C+Estimated
2024-01-30 104146-6 Left ventricular Ejection fraction - upper limit by US.2D.A3C+Estimated Ejection fraction - upper limit VFr Pt Heart.ventricle.left Qn US.2D.A3C+Estimated
2024-01-30 104145-8 Left ventricular Ejection fraction - upper limit by US.2D.A2C+Estimated Ejection fraction - upper limit VFr Pt Heart.ventricle.left Qn US.2D.A2C+Estimated
2024-01-30 104144-1 Mental health Advance directives Advance directives Find Pt {Setting} Doc Mental health
2024-01-30 104141-7 Trouble concentrating on things like school work, reading, or watching TV in last 2 weeks [Reported.PHQ] Trouble concentrating on things like school work, reading, or watching TV in last 2W Find 2W ^Patient Ord Reported.PHQ
2024-01-30 104138-3 Poor appetite, weight loss, or overeating in last 2 weeks [Reported.PHQ] Poor appetite, weight loss, or overeating in last 2W Find 2W ^Patient Ord Reported.PHQ
2024-01-30 104136-7 Little interest or pleasure in doing things in last 2 weeks [Reported.PHQ] Little interest or pleasure in doing things in last 2W Find 2W ^Patient Ord Reported.PHQ
2024-01-30 104135-9 Feeling down, depressed, irritable, or hopeless in last 2 weeks [Reported.PHQ] Feeling down, depressed, irritable, or hopeless in last 2W Find 2W ^Patient Ord Reported.PHQ
2024-01-30 104134-2 Dementia evaluation panel - Cerebral spinal fluid Dementia evaluation panel - Pt CSF -
2024-01-30 104133-4 Ethanol [Presence] in Exhaled gas Ethanol PrThr Pt Exhl gas Ord
2024-01-30 104132-6 Human papilloma virus 16 and 18 and 31 and 45+33+52+58 and 35+39+51+56+59+66+68 DNA [Interpretation] in Cervix by NAA with probe detection Human papilloma virus 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA Imp Pt Cvx Nom Probe.amp.tar
2024-01-30 104131-8 XR Salivary gland - left Single view for salivary calculus View for salivary calculus Find Pt Head>Salivary gland.left Doc XR
2024-01-30 104130-0 XR Salivary gland - right Single view for salivary calculus View for salivary calculus Find Pt Head>Salivary gland.right Doc XR
2024-01-30 104129-2 XR Salivary gland - bilateral Single view for salivary calculus View for salivary calculus Find Pt Head>Salivary gland.bilateral Doc XR
2024-01-30 104128-4 XR Salivary gland Single view for salivary calculus View for salivary calculus Find Pt Head>Salivary gland Doc XR
2024-01-29 104127-6 Cytokeratin 19 mRNA for cancer metastasis [Presence] in Lymph node by NAA with non-probe detection Cytokeratin 19 mRNA for cancer metastasis PrThr Pt Lymph node Ord Non-probe.amp.tar
2024-01-29 104126-8 Child Life Group counseling note Group counseling note Find Pt {Setting} Doc Child Life
2024-01-29 104125-0 Child Life Note Note Find Pt {Setting} Doc Child Life
2024-01-29 104124-3 Vascular Access History and physical note History and physical note Find Pt {Setting} Doc Vascular Access
2024-01-29 104123-5 Vascular Access Outpatient Note Note Find Pt Outpatient Doc Vascular Access
2024-01-29 104122-7 Vascular Access Progress Note Progress Note Find Pt {Setting} Doc Vascular Access
2024-01-29 104121-9 Vascular Access Consult note Consultation note Find Pt {Setting} Doc Vascular Access
2024-01-29 104120-1 Prevention Orchestra Project panel Prevention Orchestra Project panel - Pt ^Patient -
2024-01-29 104119-3 Breast Cancer recurrence risk multigene analysis [Presence] in Tissue by Molecular genetics method Breast Cancer recurrence risk multigene analysis PrThr Pt Tissue Ord Molgen
2024-01-29 104118-5 CD34 recipient derived/CD34 cells in Bone marrow by Molecular genetics method --post stem cell transplant Cells.CD34 recipient derived/Cells.CD34^post stem cell transplantation NFr Pt Bone mar Qn Molgen
2024-01-29 104117-7 11-Hydroxytestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS 11-Hydroxytestosterone SCnc Pt Ser/Plas Qn LC/MS/MS
2024-01-29 104116-9 Multiple sulfatase deficiency [Enzymatic activity/volume] in DBS Multiple sulfatase deficiency CCnc Pt Bld.dot Qn
2024-01-29 104115-1 heparan-alpha-glucosaminide N-acetyltransferase [Enzymatic activity/volume] in DBS heparan-alpha-glucosaminide N-acetyltransferase CCnc Pt Bld.dot Qn
2024-01-29 104114-4 Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in DBS Alpha-N-acetylglucosaminidase CCnc Pt Bld.dot Qn
2024-01-29 104113-6 Heparan-N-sulfatase [Enzymatic activity/volume] in DBS Heparan-N-sulfatase CCnc Pt Bld.dot Qn
2024-01-29 104112-8 Mucopolysaccharidosis [Enzymatic activity/volume] in DBS Mucopolysaccharidosis CCnc Pt Bld.dot Qn
2024-01-29 104111-0 Legionella pneumophila DNA [Presence] in Upper respiratory specimen by NAA with non-probe detection Legionella pneumophila DNA PrThr Pt Respiratory system specimen.upper Ord Non-probe.amp.tar
2024-01-29 104110-2 Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with non-probe detection Human bocavirus DNA PrThr Pt Respiratory system specimen.upper Ord Non-probe.amp.tar
2024-01-29 104109-4 Zolpidem [Presence] in Serum or Plasma Zolpidem PrThr Pt Ser/Plas Ord
2024-01-29 104108-6 Xylazine [Presence] in Serum or Plasma Xylazine PrThr Pt Ser/Plas Ord
2024-01-29 104107-8 traMADol [Presence] in Serum or Plasma Tramadol PrThr Pt Ser/Plas Ord
2024-01-29 104106-0 Pregabalin [Presence] in Serum or Plasma Pregabalin PrThr Pt Ser/Plas Ord
2024-01-29 104105-2 Ethyl glucuronide [Presence] in Serum or Plasma Ethyl glucuronide PrThr Pt Ser/Plas Ord
2024-01-28 104104-5 Mental Health Household Members panel Mental Health Household Members panel - Pt ^Patient -
2024-01-28 104103-7 Cumulative fluid balance Cumulative fluid balance VRat Pt ^Patient Qn
2024-01-28 104102-9 Hospital discharge timestamp Hospital discharge timestamp TmStp Pt ^Patient Qn
2024-01-28 104101-1 Hospital admission timestamp Hospital admission timestamp TmStp Pt ^Patient Qn
2024-01-28 104100-3 Hospital admission ID Hospital admission ID ID Pt ^Patient Nom
2024-01-28 104099-7 ICU admission ID ICU admission ID ID Pt ^Patient Nom
2024-01-28 104098-9 Intensive care unit discharge timestamp Intensive care unit discharge timestamp TmStp Pt ^Patient Qn
2024-01-28 104097-1 Intensive care unit admission timestamp Intensive care unit admission timestamp TmStp Pt ^Patient Qn
2024-01-28 104095-5 Blood flow.ECMO of Circulatory system Blood flow.ECMO VRat Pt {Circulatory system} Qn
2024-01-28 104094-8 Alive and without mechanical ventilation [Score] 3 weeks by - Reported Alive and without mechanical ventilation Score 3W ^Patient Qn Reported
2024-01-28 104093-0 Alive and without mechanical ventilation [Score] 2 minutes by - Reported Alive and without mechanical ventilation Score 2M ^Patient Qn Reported
2024-01-28 104092-2 Alive and without mechanical ventilation [Score] 4 weeks by - Reported Alive and without mechanical ventilation Score 4W ^Patient Qn Reported
2024-01-28 104091-4 FDA product label Animal drug for further processing Animal drug for further processing Find Pt ^FDA product label Nar
2024-01-28 104090-6 FDA product label Cosmetic-abbreviated renewal Cosmetic-abbreviated renewal Find Pt ^FDA product label Nar
2024-01-28 104089-8 FDA product label Cosmetic facility registration-biennial renewal Cosmetic facility registration-biennial renewal Find Pt ^FDA product label Nar
2024-01-28 104088-0 FDA product label Cosmetic facility registration-cancellation Cosmetic facility registration-cancellation Find Pt ^FDA product label Nar
2024-01-28 104087-2 FDA product label Cosmetic facility registration-abbreviated renewal Cosmetic facility registration-abbreviated renewal Find Pt ^FDA product label Nar
2024-01-28 104086-4 FDA product label Cosmetic facility registration-amendment Cosmetic facility registration-amendment Find Pt ^FDA product label Nar
2024-01-28 104085-6 FDA product label Cosmetic facility registration Cosmetic facility registration Find Pt ^FDA product label Nar
2024-01-28 104084-9 Children and work family balance panel Children and work family balance panel - Pt ^Patient -
2024-01-28 104083-1 Rate of the balance between your work and family commitments in last 3 months Rate of the balance between your work and family commitments in last 3M Find Pt ^Patient Ord
2024-01-28 104082-3 In 2020 how would you rate the balance between your work and family commitments at the time In 2020 how would you rate the balance between your work and family commitments at the time Find Pt ^Patient Ord
2024-01-28 104081-5 Childcare from a provider or person outside the household was available in past 3 months Childcare from a provider or person outside the household was available in past 3M Find Pt ^Patient Ord
2024-01-28 104080-7 Childcare from a provider or person outside the household was available in 2020 Childcare from a provider or person outside the household was available in 2020 Find Pt ^Patient Ord
2024-01-28 104079-9 Frequency of you or who was in charge of taking care of these underage persons in last 3 months Frequency of you or who was in charge of taking care of these underage persons in last 3M Find Pt ^Patient Ord
2024-01-28 104078-1 Number of underage persons in household Number of underage persons in household Num Pt ^Patient Qn
2024-01-28 104077-3 Are underage people living in household Are underage people living in household Find Pt ^Patient Ord
2024-01-28 104076-5 Basic metabolic with hemoglobin and hematocrit panel - Blood Basic metabolic & hemoglobin & hematocrit panel - Pt Bld -
2024-01-27 104075-7 Gas and Lactate panel - Venous blood Gas & Lactate panel - Pt BldV -
2024-01-27 104074-0 Gas and Lactate panel - Arterial blood Gas & Lactate panel - Pt BldA -
2024-01-27 104073-2 Multiple sulfatase deficiency enzymes panel - Leukocytes Multiple sulfatase deficiency enzymes panel - Pt WBC -
2024-01-27 104072-4 Mucopolysaccharidosis enzymes panel - Leukocytes Mucopolysaccharidosis enzymes panel - Pt WBC -
2024-01-27 104071-6 Cystoscopy study Document Cystoscopy study Find Stdy ^Patient Doc
2024-01-27 104070-8 Outpatient Audiology note Audiology note Find Pt Outpatient Doc {Role}
2024-01-27 104069-0 Hospitalist Transfer summary note Transfer summary note Find Pt {Setting} Doc Hospitalist
2024-01-27 104068-2 Hospitalist Admission evaluation note Admission evaluation note Find Pt {Setting} Doc Hospitalist
2024-01-27 104067-4 Hospitalist Assessment note Assessment note Find Pt {Setting} Doc Hospitalist
2024-01-27 104066-6 Hospitalist Outpatient Consult note Consultation note Find Pt Outpatient Doc Hospitalist
2024-01-26 104065-8 CTA Head W contrast and CTA Neck WO and W contrast IV Multisection^W contrast IV && Multisection^WO & W contrast IV Find Pt Head && Neck Doc CT.angio && CT.angio
2024-01-26 104064-1 Medical specialty responsible for patient after ICU discharge Intensive Care Unit {ICU} specialty destination Type Pt ^Patient Nominal
2024-01-26 104063-3 Body temperature - Groin Body temperature Temp Pt Groin Qn
2024-01-26 104062-5 HISGT Histone genes targeted mutation analysis in Tumor by Molecular genetics method HISGT Histone genes targeted mutation analysis Find Pt Tumor Doc Molgen
2024-01-26 104060-9 When contacting people outside of household have you kept a minimum of 1.5 to 2 meters away When contacting people outside of household have you kept a minimum of 1.5 to 2 meters away Find Pt ^Patient Ord
2024-01-26 104059-1 Have you been to any other places or events not yet specified Specify if you go to any other places or events Find Pt ^Patient Nar
2024-01-26 104058-3 Were you obliged to follow the vaccinated-tested-recovered rule in last 2 weeks Follow the vaccinated-tested-recovered rule last 2W Find Pt ^Patient Nom
2024-01-26 104057-5 Were you obliged to wear masks in open public areas in last 2 weeks Were you obliged to wear masks in open public areas in last 2W Find Pt ^Patient Ord
2024-01-26 104056-7 Were you obliged to wear masks in closed public areas in last 2 weeks Were you obliged to wear masks in closed public areas in last 2W Find 2W ^Patient Ord
2024-01-26 104055-9 Did you work remotely at home completely or only on several days per week during last 2 weeks Did you work remotely at home completely or only on several D per W during last 2W Find 2W ^Patient Ord
2024-01-26 104054-2 Have the schools been closed in last 2 weeks Have the schools been closed in last 2W Find 2W ^Patient Ord
2024-01-26 104053-4 Have you been in lockdown in last 2 weeks Have you been in lockdown in last 2W Find 2W ^Patient Ord
2024-01-26 104052-6 Lifestyle Factors panel Lifestyle Factors panel - Pt ^Patient -
2024-01-26 104051-8 Fetal Pelvis for pregnancy in second trimester Multisection for pregnancy+second trimester Find Pt Pelvis+^Fetus Nom US
2024-01-26 104050-0 Was there any time when the following kinds of mental health care but could not afford it in the past 12 months Was there any time when the following kinds of mental health care but could not afford it in the past 12M Find 12Mo ^Patient Ord
2024-01-26 104049-2 Was there any time when you needed prescribed medicines but could not afford it in past 12 months Was there any time when you needed prescribed medicines but could not afford it in last 12M Find 12Mo ^Patient Ord
2024-01-26 104048-4 Bed identification Bed identification ID Pt ^Patient Nom
2024-01-26 104047-6 10-meter walking distance [Time] 10-meter walking distance Time Pt ^Patient Qn
2024-01-26 104046-8 Number of steps to walk 10-meters Number of steps to walk 10-meters Num Pt ^Patient Qn
2024-01-25 104045-0 Tracheobronchial toileting Tracheobronchial toilet occurence Find Pt ^Patient Nominal Bronchoscopy
2024-01-25 104043-5 Was there any time when you needed dental care but could not afford it in past 12 months Was there any time when you needed dental care but could not afford it in past 12M Find 12Mo ^Patient Ord
2024-01-25 104042-7 Was there any time when you needed medical care, but could not afford it in past 12 months Was there any time when you needed medical care, but could not afford it in past 12M Find 12Mo ^Patient Ord
2024-01-25 104041-9 Have you had a delay in healthcare due to distance or transport problems in past 12 months Have you had a delay in healthcare due to distance or transport problems in past 12M Find 12Mo ^Patient Ord
2024-01-25 104040-1 Unmet Healthcare Needs panel Unmet Healthcare Needs panel - Pt ^Patient -
2024-01-25 104039-3 Have you experienced a delay in healthcare due to time needed to obtain an appointment was too long in past 12 months Have you had a delay in healthcare due to time to obtain an appointment in past 12M Find 12Mo ^Patient Ord
2024-01-25 104038-5 Hendrich II fall risk assessment interpretation Hendrich II fall risk assessment interpretation Imp Pt ^Patient Ord
2024-01-25 104037-7 Hendrich II total score Hendrich II total score Score Pt ^Patient Qn Observed.Hendrich II
2024-01-25 104036-9 Get-up-and-go test: rising from a chair Get-up-and-go test: rising from a chair Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104035-1 Any administered [Benzodiazepines] Any administered [Benzodiazepines] Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104034-4 Any administered antiepileptics [Anticonvulsants] Any administered antiepileptics [Anticonvulsants] Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104033-6 Gender [born male or identifies as male] Gender [born male or identifies as male] Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104032-8 Dizziness, vertigo Dizziness, vertigo Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104031-0 Altered elimination Altered elimination Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104030-2 Symptomatic depression Symptomatic depression Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104029-4 Confusion, disorientation, and impulsivity Confusion, disorientation, and impulsivity Find Pt ^Patient Ord Observed.Hendrich II
2024-01-25 104028-6 Hendrich II fall risk model Hendrich II fall risk - Pt ^Patient - Observed.Hendrich II
2024-01-25 104027-8 Bile acid malabsorption panel Bile acid malabsorption panel - Pt ^Patient -
2024-01-24 104006-2 Trust in Science and Scientist Inventory Trust in Science and Scientist Inventory - Pt ^Patient -
2024-01-24 104005-4 Information to tell doctors if you experience failing health with a low chance of recovery [Reported] Information to tell doctors if you experience failing health with a low chance of recovery Find Pt ^Patient Nar Reported
2024-01-23 104004-7 US for pregnancy in third trimester Multisection for pregnancy+third trimester Find Pt Pelvis+^Fetus Nom US
2024-01-23 103999-9 IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge during assessment period [CMS Assessment] IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge - RptPeriod ^Patient - CMS Assessment
2024-01-23 103998-1 IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission during assessment period [CMS Assessment] IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission - RptPeriod ^Patient - CMS Assessment
2024-01-22 103997-3 Type of mechanical circulatory support Type of mechanical circulatory support Find Pt ^Patient Nom
2024-01-22 103996-5 In 2020 was it you or who was in charge of taking care of these underage persons In 2020 was it you or who was in charge of taking care of these underage persons Find Pt ^Patient Ord
2024-01-22 103991-6 CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 4.2 during assessment period [CMS Assessment] CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.2 - RptPeriod ^Patient - CMS Assessment
2024-01-22 103986-6 Do you have a personal safety insecurity Do you have a personal safety insecurity - Pt ^Patient - SDOH
2024-01-22 103985-8 Do you have utilities insecurity Do you have utilities insecurity - Pt ^Patient - SDOH
2024-01-22 103984-1 Do you have a travel insecurity Do you have a travel insecurity - Pt ^Patient - SDOH
2024-01-22 103983-3 Do you have a housing insecurity Do you have a housing insecurity - Pt ^Patient - SDOH
2024-01-22 103982-5 Do you have a food insecurity Do you have a food insecurity - Pt ^Patient - SDOH
2024-01-22 103981-7 Do you feel physically or emotionally unsafe where you currently live Do you feel physically or emotionally unsafe where you currently live - Pt ^Patient - SDOH
2024-01-22 103980-9 Pharmacy preference [Reported] Pharmacy preference Find Pt ^Patient Nar Reported
2024-01-22 103979-1 Information to tell the medical team if you stop breathing or your heart stops beating [Reported] Information to tell the medical team if you stop breathing or your heart stops beating Find Pt ^Patient Nar Reported
2024-01-22 103978-3 Information to tell doctors if you have a sudden injury or illness with a good chance of recovery [Reported] Information to tell doctors if you have a sudden injury or illness with a good chance of recovery Find Pt ^Patient Nar Reported
2024-01-22 103977-5 State of commission Notary [Reported] State of commission Find Pt ^Notary Nom Reported
2024-01-22 103976-7 Mobility Episode Mobility Find Episode ^Patient Ord
2024-01-22 103975-9 Previous delivery date Previous delivery date Date Pt ^Patient Qn
2024-01-22 103974-2 Ectopic pregnancy AndOr abortion [#] Ectopic pregnancy &or abortion Num Pt ^Patient Qn Reported
2024-01-22 103973-4 Paternal age at fetal death Paternal age at fetal death Time Pt ^Patient Qn
2024-01-22 103972-6 Cardiology Outpatient Rehabilitation Note Rehabilitation Note Find Pt Outpatient Doc Cardiovascular disease
2024-01-22 103971-8 Cardiology Rehabilitation progress note Rehabilitation progress note Find Pt {Setting} Doc Cardiovascular disease
2024-01-22 103970-0 Cardiology Rehabilitation Note Rehabilitation note Find Pt {Setting} Doc Cardiovascular disease
2024-01-22 103969-2 Hospice care Progress note Progress Note Find Pt {Setting} Doc Hospice care
2024-01-22 103968-4 Hospice care Consult note Consultation note Find Pt {Setting} Doc Hospice care
2024-01-22 103967-6 Hospice care nurse Note Note Find Pt {Setting} Doc Hospice care.nurse
2024-01-22 103966-8 Hospice care case manager Note Note Find Pt {Setting} Doc Hospice care.case manager
2024-01-22 103965-0 Hospice care Interdisciplinary Note Note Find Pt {Setting} Doc Hospice care.Interdisciplinary
2024-01-22 103964-3 Hospice care social worker Note Note Find Pt {Setting} Doc Hospice care.social worker
2024-01-19 103963-5 Zika virus lineage [Identifier] in Specimen by Molecular genetics method Zika virus lineage Prid Pt XXX Nom Molgen
2024-01-19 103962-7 11-Ketotestosterone [Moles/volume] in Serum or Plasma by LC/MS/MS 11-Ketotestosterone SCnc Pt Ser/Plas Qn LC/MS/MS
2024-01-18 103961-9 Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Cerebral spinal fluid by Immunoassay Borrelia burgdorferi.VlsE1+pepC10 Ab ACnc Pt CSF Qn IA
2024-01-18 103960-1 Prothionamide [Susceptibility] by Genotype method Prothionamide Susc Pt Isolate Ord Genotyping
2024-01-18 103959-3 cycloSERINE [Susceptibility] by Genotype method Cycloserine Susc Pt Isolate Ord Genotyping
2024-01-18 103958-5 Ofloxacin [Susceptibility] by Genotype method Ofloxacin Susc Pt Isolate Ord Genotyping
2024-01-17 103957-7 Neuromuscular multigene analysis in Specimen by Molecular genetics method Neuromuscular multigene analysis Find Pt XXX Doc Molgen
2024-01-17 103956-9 Parkinson Disease multigene analysis in Specimen by Molecular genetics method Parkinson Disease multigene analysis Find Pt XXX Doc Molgen
2024-01-17 103955-1 KRAS Somatic mutation analysis in Tumor by Molecular genetics method KRAS Somatic mutation analysis Find Pt Tumor Doc Molgen
2024-01-17 103954-4 Peripheral neuropathy multigene analysis in Specimen by Molecular genetics method Peripheral neuropathy multigene analysis Find Pt XXX Doc Molgen
2024-01-17 103953-6 HIF2A gene targeted mutation analysis in Blood by Molecular genetics method HIF2A gene targeted mutation analysis Find Pt Bld Doc Molgen
2024-01-17 103952-8 Muscular dystrophy multigene analysis in Specimen by Molecular genetics method Muscular dystrophy multigene analysis Find Pt XXX Doc Molgen
2024-01-17 103951-0 Motor neuron disease multigene analysis in Specimen by Molecular genetics method Motor neuron disease multigene analysis Find Pt XXX Doc Molgen
2024-01-17 103950-2 NOTCH3 gene full mutation analysis in Specimen by Molecular genetics method NOTCH3 gene full mutation analysis Find Pt XXX Doc Molgen
2024-01-16 103949-4 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1 during assessment period [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1 - RptPeriod ^Patient - CMS Assessment
2024-01-16 103948-6 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1 during assessment period [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1 - RptPeriod ^Patient - CMS Assessment
2024-01-16 103947-8 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.1 during assessment period [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.1 - RptPeriod ^Patient - CMS Assessment
2024-01-12 103946-0 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.1 during assessment period [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.1 - RptPeriod ^Patient - CMS Assessment
2024-01-12 103945-2 CT Neck+Chest+Abdomen W contrast IV Multisection^W contrast IV Find Pt Neck+Chest+Abdomen Doc CT
2024-01-12 103944-5 CT Neck+Chest+Abdomen WO contrast Multisection^WO contrast Find Pt Neck+Chest+Abdomen Doc CT
2024-01-12 103942-9 Mental health of household members comments Mental health of household members comments Imp Pt ^Patient Nar
2024-01-12 103941-1 For each underage person what would you say how is the mental health of underage person For each underage person what would you say how is the mental health of underage person Find Pt ^Patient Ord
2024-01-12 103939-5 Do you have underage persons in your household Do you have underage persons in your household Find Pt ^Patient Ord
2024-01-12 103938-7 What would you say is the quality of your partnership What would you say is the quality of your partnership Find Pt ^Patient Ord
2024-01-12 103937-9 What would you say how is the mental health of your partner is What would you say how is the mental health of your partner is Find Pt ^Patient Ord
2024-01-12 103936-1 Which household type do you live in Which household type do you live in Find Pt ^Patient Ord
2024-01-12 103935-3 Are you in a committed relationship Are you in a committed relationship Find Pt ^Patient Ord
2024-01-12 103934-6 How many hours per day have you spent on streaming platforms over the past 2 weeks How many H per D have you spent on streaming platforms over the past 2W Time Pt ^Patient Qn
2024-01-12 103933-8 How many hours per day have you spent speaking with friends or family over the past 2 weeks How many H per D have you spent speaking with friends or family over the past 2W Time Pt ^Patient Qn
2024-01-12 103932-0 How many hours per day have you spent watching news on television over the past 2 weeks How many H per D have you spent watching news on television over the past 2W Time Pt ^Patient Qn
2024-01-12 103931-2 How many hours per day have you spent on social media platforms over the past 2 weeks How many H per D have you spent on social media platforms over the past 2W Time Pt ^Patient Qn
2024-01-12 103930-4 Blood volume Unspecified body region CVVHD Blood volume VRat Pt XXX Qn CVVHD
2024-01-12 103929-6 Blood flow rate Unspecified body region CVVH Blood flow rate VRat Pt XXX Qn CVVH
2024-01-12 103927-0 US.doppler Lower extremity artery - left limited Multisection limited Find Pt Lower extremity.left>Lower extremity artery Doc US.doppler
2024-01-12 103928-8 US.doppler Lower extremity artery - right limited Multisection limited Find Pt Lower extremity.right>Lower extremity artery Doc US.doppler
2024-01-12 103926-2 US.doppler Vein - bilateral Multisection Find Pt XXX>Vein.bilateral Doc US.doppler
2024-01-12 103925-4 US Lower extremity artery - right limited Multisection limited Find Pt Lower extremity.right>Lower extremity artery Doc US
2024-01-12 103924-7 US Lower extremity artery - left limited Multisection limited Find Pt Lower extremity.left>Lower extremity artery Doc US
2024-01-12 103923-9 US Lower extremity vein - right limited Multisection limited Find Pt Lower extremity.right>Lower extremity vein Doc US
2024-01-12 103922-1 US Lower extremity vein - left limited Multisection limited Find Pt Lower extremity.left>Lower extremity vein Doc US
2024-01-12 103921-3 US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava limited Multisection limited Find Pt Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior Doc US.doppler
2024-01-12 103920-5 US.doppler Thoracic and Abdominal Aorta and Inferior Vena Cava Multisection Find Pt Chest>Aorta.thoracic & Abdomen>Aorta.abdominal+Vena cava.inferior Doc US.doppler
2024-01-12 103919-7 US.doppler Abdominal Aorta Multisection Find Pt Abdomen>Aorta.abdominal Doc US.doppler
2024-01-12 103918-9 US.doppler Thoracic and abdominal aorta limited Multisection limited Find Pt Chest>Aorta.thoracic & Abdomen>Aorta.abdominal Doc US.doppler
2024-01-12 103916-3 US Vein - right Multisection Find Pt XXX>Vein.right Doc US
2024-01-12 103917-1 US Axilla - bilateral Multisection Find Pt Chest>Axilla.bilateral Doc US
2024-01-12 103914-8 US Groin - right Multisection Find Pt Pelvis>Groin.right Doc US
2024-01-12 103915-5 US Vein - left Multisection Find Pt XXX>Vein.left Doc US
2024-01-12 103913-0 US Groin - left Multisection Find Pt Pelvis>Groin.left Doc US
2024-01-12 103912-2 US Extremity vein - bilateral Multisection Find Pt Extremity.bilateral>Extremity vein Doc US
2024-01-12 103911-4 US Chest - right Multisection Find Pt Chest.right Doc US
2024-01-12 103910-6 US Chest - left Multisection Find Pt Chest.left Doc US
2024-01-12 103909-8 US Abdominal Aorta limited Multisection limited Find Pt Abdomen>Aorta.abdominal Doc US
2024-01-12 103906-4 US.doppler Renal vessels - right Multisection Find Pt Abdomen>Renal vessels.right Doc US.doppler
2024-01-12 103903-1 US Kidney - left limited Multisection limited Find Pt Abdomen>Kidney.left Doc US
2024-01-12 103904-9 US Kidney - right limited Multisection limited Find Pt Abdomen>Kidney.right Doc US
2024-01-12 103905-6 US.doppler Renal vessels - left Multisection Find Pt Abdomen>Renal vessels.left Doc US.doppler
2024-01-12 103901-5 US Abdomen and Pelvis Multisection Find Pt Abdomen+Pelvis Doc US
2024-01-12 103902-3 US.doppler Abdomen and Pelvis Multisection Find Pt Abdomen+Pelvis Doc US.doppler
2024-01-12 103893-4 MG Breast Screening for implant Views screening for implant Find Pt Breast Doc MG
2024-01-12 103894-2 MG Breast Diagnostic for implant Views diagnostic for implant Find Pt Breast Doc MG
2024-01-12 103892-6 DBT Breast screening Multisection screening Find Pt Breast Doc MG.tomosynthesis
2024-01-12 103890-0 MG stereo Guidance for localization of Breast - left Guidance for localization Find Pt Breast.left Doc MG.stereotactic
2024-01-12 103891-8 MG stereo Guidance for localization of Breast - right Guidance for localization Find Pt Breast.right Doc MG.stereotactic
2024-01-12 103889-2 MG stereo Guidance for localization of Breast - bilateral Guidance for localization Find Pt Breast.bilateral Doc MG.stereotactic
2024-01-12 103888-4 MG Guidance for needle localization of Breast Guidance for needle localization Find Pt Breast Doc MG
2024-01-12 103886-8 MG Breast - right Screening for implant Views screening for implant Find Pt Breast.right Doc MG
2024-01-12 103887-6 MG Breast duct - bilateral Single view W contrast intra duct View^W contrast intra duct Find Pt Breast>Breast duct.bilateral Doc MG
2024-01-12 103885-0 MG Breast - left Screening for implant Views screening for implant Find Pt Breast.left Doc MG
2024-01-12 103884-3 CT Wrist - bilateral WO and W contrast IV Multisection^WO & W contrast IV Find Pt Upper extremity.bilateral>Wrist Doc CT
2024-01-12 103882-7 CT Mastoid WO and W contrast IV Multisection^WO & W contrast IV Find Pt Head>Mastoid Doc CT
2024-01-12 103883-5 CT Foot - bilateral WO and W contrast IV Multisection^WO & W contrast IV Find Pt Lower extremity.bilateral>Foot Doc CT
2024-01-12 103881-9 CT Mastoid WO contrast Multisection^WO contrast Find Pt Head>Mastoid Doc CT
2024-01-12 103879-3 CT Forearm - bilateral WO and W contrast IV Multisection^WO & W contrast IV Find Pt Upper extremity.bilateral>Forearm Doc CT
2024-01-12 103880-1 CT Ankle - bilateral WO and W contrast IV Multisection^WO & W contrast IV Find Pt Lower extremity.bilateral>Ankle Doc CT
2024-01-12 103878-5 CT Forearm - bilateral WO contrast Multisection^WO contrast Find Pt Upper extremity.bilateral>Forearm Doc CT
2024-01-12 103876-9 CT Pelvis W contrast PO and W contrast IV Multisection^W contrast PO+W contrast IV Find Pt Pelvis Doc CT
2024-01-12 103877-7 CT Forearm - bilateral W contrast IV Multisection^W contrast IV Find Pt Upper extremity.bilateral>Forearm Doc CT
2024-01-12 103875-1 CT Pelvis W contrast PO Multisection^W contrast PO Find Pt Pelvis Doc CT
2024-01-12 103873-6 CT Sella turcica and Orbit - bilateral WO and W contrast IV Multisection^WO & W contrast IV Find Pt Head>Sella turcica+Orbit.bilateral Doc CT
2024-01-12 103874-4 CT Chest and Abdomen Multisection Find Pt Chest+Abdomen Doc CT
2024-01-12 103872-8 CT Sella turcica and Orbit - bilateral W contrast IV Multisection^W contrast IV Find Pt Head>Sella turcica+Orbit.bilateral Doc CT
2024-01-12 103870-2 CT Sella turcica and Orbit - bilateral Multisection Find Pt Head>Sella turcica+Orbit.bilateral Doc CT
2024-01-12 103871-0 CT Sella turcica and Orbit - bilateral WO contrast Multisection^WO contrast Find Pt Head>Sella turcica+Orbit.bilateral Doc CT
2024-01-12 103869-4 CT Sella turcica and Orbit WO and W contrast IV Multisection^WO & W contrast IV Find Pt Head>Sella turcica+Orbit Doc CT
2024-01-12 103867-8 CT Lower leg - bilateral WO and W contrast IV Multisection^WO & W contrast IV Find Pt Lower extremity.bilateral>Lower leg Doc CT
2024-01-12 103868-6 CT Sella turcica and Orbit WO contrast Multisection^WO contrast Find Pt Head>Sella turcica+Orbit Doc CT
2024-01-12 103866-0 CT Lower leg - bilateral W contrast IV Multisection^W contrast IV Find Pt Lower extremity.bilateral>Lower leg Doc CT
2024-01-12 103865-2 CT Shoulder - bilateral WO and W contrast IV Multisection^WO & W contrast IV Find Pt Upper extremity.bilateral>Shoulder Doc CT
2024-01-12 103864-5 CT Sella turcica and Orbit W contrast IV Multisection^W contrast IV Find Pt Head>Sella turcica+Orbit Doc CT
2024-01-12 103863-7 CT Kidney and Ureter and Urinary bladder W contrast IV Multisection^W contrast IV Find Pt Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder Doc CT
2024-01-12 103862-9 CT Facial bones WO and W contrast IV Multisection^WO & W contrast IV Find Pt Head>Facial bones Doc CT
2024-01-12 103861-1 CT Abdomen W contrast PO and W contrast IV Multisection^W contrast PO+W contrast IV Find Pt Abdomen Doc CT
2024-01-12 103860-3 CT Abdomen W contrast PO Multisection^W contrast PO Find Pt Abdomen Doc CT
2024-01-12 103859-5 CT Abdomen and Pelvis W contrast PO and W contrast IV Multisection^W contrast PO+W contrast IV Find Pt Abdomen+Pelvis Doc CT
2024-01-12 103858-7 XR and RF Chest GE 2 Views and Views Views GE 2 && Views Find Pt Chest Doc XR && RF
2024-01-12 103857-9 RFA Vertebral vessels Right Views W contrast IA Views^W contrast IA Find Pt Head+Neck>Vertebral vessels.right Doc RF.angio
2024-01-12 103856-1 RFA Vertebral vessels Left Views W contrast IA Views^W contrast IA Find Pt Head+Neck>Vertebral vessels.left Doc RF.angio
2024-01-12 103855-3 RFA Carotid artery.internal - bilateral Views W contrast IA Views^W contrast IA Find Pt Head+Neck>Carotid artery.internal.bilateral Doc RF.angio
2024-01-12 103854-6 RFA Guidance for angioplasty of Extremity vessels - right -- W contrast Guidance for angioplasty^W contrast Find Pt Extremity>Extremity vessels.right Doc RF.angio
2024-01-12 103853-8 RFA Guidance for angioplasty of Extremity vessels - left -- W contrast Guidance for angioplasty^W contrast Find Pt Extremity>Extremity vessels.left Doc RF.angio
2024-01-12 103852-0 RFA Guidance for angioplasty of Extremity vessels - bilateral -- W contrast Guidance for angioplasty^W contrast Find Pt Extremity>Extremity vessels.bilateral Doc RF.angio
2024-01-12 103851-2 RF Urethra Views W contrast retrograde via urethra Views^W contrast retrograde via urethra Find Pt Pelvis>Urethra Doc RF
2024-01-12 103850-4 RF Kidney Views W contrast via nephrostomy tube Views^W contrast via nephrostomy tube Find Pt Abdomen>Kidney Doc RF
2024-01-12 103849-6 RF Guidance for removal of foreign body from Esophagus Guidance for removal of foreign body Find Pt Chest>Esophagus Doc RF
2024-01-12 103848-8 RF Spine Lumbar and Sacrum Views W contrast IT Views^W contrast IT Find Pt Abdomen>Spine.lumbar & Pelvis>Sacrum Doc RF
2024-01-09 103846-2 How many hours per day have you spent surfing the net over the last 2 weeks How many H per D have you spent surfing the net over the past 2W Find Pt ^Patient Ord
2024-01-08 103845-4 Fat/Total solids [Mass Ratio] in 72 hour Stool Fat/Solids.total MRto 72H Stool Qn
2024-01-08 103844-7 HBA1 and HBA2 gene deletion in Amniotic fluid or Chorionic villus sample by Molecular genetics method HBA1 & HBA2 gene deletion Find Pt Amnio fld/CVS Doc Molgen
2024-01-05 103843-9 Tripartite motif containing 46 [Presence] in Specimen by Immunofluorescence Tripartite motif containing 46 PrThr Pt XXX Ord IF
2024-01-05 103842-1 Phosphodiesterase 10A Ab [Presence] in Serum or Plasma and CSF by Immunofluorescence Phosphodiesterase 10A Ab PrThr Pt Ser/Plas+CSF Ord IF
2024-01-04 103841-3 Zolpidem [Presence] in Meconium Zolpidem PrThr Pt Meconium Ord
2024-01-04 103840-5 Tapentadol [Presence] in Meconium Tapentadol PrThr Pt Meconium Ord
2024-01-04 103839-7 Phentermine [Presence] in Meconium Phentermine PrThr Pt Meconium Ord
2024-01-04 103838-9 oxyMORphone [Presence] in Meconium Oxymorphone PrThr Pt Meconium Ord
2024-01-04 103837-1 O-desmethyltraMADol [Presence] in Meconium O-desmethyltramadol PrThr Pt Meconium Ord
2024-01-04 103836-3 Noroxycodone [Presence] in Meconium Noroxycodone PrThr Pt Meconium Ord
2024-01-04 103835-5 Norhydrocodone [Presence] in Meconium Norhydrocodone PrThr Pt Meconium Ord
2024-01-04 103834-8 Norbuprenorphine [Presence] in Meconium Norbuprenorphine PrThr Pt Meconium Ord
2024-01-04 103833-0 N-nortramadol [Presence] in Meconium N-nortramadol PrThr Pt Meconium Ord
2024-01-04 103832-2 Naloxone [Presence] in Meconium Naloxone PrThr Pt Meconium Ord
2024-01-04 103831-4 Midazolam [Presence] in Meconium Midazolam PrThr Pt Meconium Ord
2024-01-04 103830-6 Gabapentin [Presence] in Meconium Gabapentin PrThr Pt Meconium Ord
2024-01-04 103829-8 Dihydrocodeine [Presence] in Meconium Dihydrocodeine PrThr Pt Meconium Ord
2024-01-04 103828-0 1-Hydroxymidazolam [Presence] in Meconium 1-Hydroxymidazolam PrThr Pt Meconium Ord
2024-01-04 103827-2 Long term care facility Medication management note Medication Management Note Find Pt Long term care facility Doc
2024-01-04 103825-6 Hepatology Medication management note Medication Management Note Find Pt {Setting} Doc Hepatology
2024-01-04 103826-4 Infectious disease Medication management note Medication Management Note Find Pt {Setting} Doc Infectious disease
2024-01-04 103824-9 Hematology Medication management note Medication Management Note Find Pt {Setting} Doc Hematology
2024-01-04 103823-1 Geriatric medicine Medication management note Medication Management Note Find Pt {Setting} Doc Geriatric medicine
2024-01-04 103822-3 Endocrinology Medication management note Medication Management Note Find Pt {Setting} Doc Endocrinology
2024-01-04 103821-5 Emergency medicine Medication management note Medication Management Note Find Pt {Setting} Doc Emergency medicine
2024-01-04 103820-7 Dialysis Medication management note Medication Management Note Find Pt {Setting} Doc Dialysis
2024-01-04 103819-9 Dermatology Medication management note Medication Management Note Find Pt {Setting} Doc Dermatology
2024-01-04 103818-1 Critical care medicine Medication management note Medication Management Note Find Pt {Setting} Doc Critical Care Medicine
2024-01-04 103816-5 Bone Marrow Transplant Medication management note Medication Management Note Find Pt {Setting} Doc Bone marrow transplant
2024-01-04 103817-3 Cardiology Medication management note Medication Management Note Find Pt {Setting} Doc Cardiovascular disease
2024-01-04 103815-7 Pneumonia probability [Likelihood] Artificial intelligence based calculation Pneumonia probability Likelihood Pt ^Patient Qn Artificial intelligence based calculation
2024-01-04 103814-0 CT Study observation Narrative Study observation Find Pt Lower GI tract Nar CT
2024-01-04 103813-2 Domestic violence screening report Domestic violence screening report Find Pt {Setting} Doc
2024-01-04 103812-4 Patient state index Cerebral cortex Electroencephalogram (EEG) Patient state index Score Pt Cerebral cortex Qn EEG
2024-01-04 103811-6 Pulse pressure by Noninvasive Pulse pressure PressDiff Pt Arterial system Qn Noninvasive
2024-01-04 103810-8 Pulse pressure by Invasive Pulse pressure PressDiff Pt Arterial system Qn Invasive
2024-01-04 103809-0 Allergy Medication management note Medication Management Note Find Pt {Setting} Doc Allergy
2024-01-04 103808-2 Allergy and Immunology Medication management note Medication Management Note Find Pt {Setting} Doc Allergy+Immunology
2024-01-04 103807-4 Hematology Referral note Referral note Find Pt {Setting} Doc Hematology
2024-01-04 103806-6 Oncology Telephone encounter Note Note Find Pt Telephone encounter Doc Oncology
2024-01-04 103805-8 Bariatric surgery Referral note Referral note Find Pt {Setting} Doc Bariatric surgery
2024-01-04 103804-1 Surgical oncology Outpatient Progress note Progress note Find Pt Outpatient Doc Surgical oncology
2024-01-04 103803-3 Surgery Outpatient Progress note Progress note Find Pt Outpatient Doc Surgery
2024-01-04 103802-5 Medical oncology.team Conference note Conference note Find Pt {Setting} Doc Medical oncology.team
2024-01-04 103801-7 Speech-language pathology Outpatient Note Note Find Pt Outpatient Doc Speech-language pathology
2024-01-04 103800-9 Mental health Summary note Summary note Find Pt {Setting} Doc Mental health
2024-01-04 103799-3 Healthcare navigator Consult note Consultation note Find Pt {Setting} Doc Healthcare navigator
2024-01-04 103798-5 Child and adolescent psychiatry Outpatient Note Note Find Pt Outpatient Doc Child and adolescent psychiatry
2024-01-04 103797-7 Audiology Outpatient Note Note Find Pt Outpatient Doc Audiology
2024-01-04 103796-9 Outpatient Instructions Instructions Find Pt Outpatient Doc {Role}
2024-01-04 103795-1 Outpatient Discharge instructions Discharge instructions Find Pt Outpatient Doc {Role}
2024-01-04 103794-4 Psychiatry Outpatient Consult note Consultation note Find Pt Outpatient Doc Psychiatry
2024-01-04 103793-6 Mental health Outpatient Consult note Consultation note Find Pt Outpatient Doc Mental health
2024-01-04 103792-8 Mental health Annual evaluation note Annual evaluation note Find Pt {Setting} Doc Mental health
2024-01-04 103791-0 Infliximab and Infliximab Ab Panel - Serum or Plasma Infliximab and Infliximab Ab Panel - Pt Ser/Plas -
2024-01-04 103790-2 Renal calculus risk assessment [Likelihood] in 24 hour Urine Narrative Renal calculus risk assessment Likelihood 24H Urine Nar
2024-01-04 103789-4 Aeromonas and plesiomonas sp identified in Stool by Organism specific culture Aeromonas & plesiomonas sp identified Prid Pt Stool Nom Organism specific culture
2024-01-04 103788-6 Bacteria Identification and Susceptibilty in Positive blood culture Document Bacteria Identification and Susceptibilty Find Pt Bld.pos growth Doc
2024-01-04 103787-8 Influenza A H3N2V RNA [Presence] in Specimen by NAA with probe detection Influenza A H3N2V RNA PrThr Pt XXX Ord Probe.amp.tar
2024-01-04 103786-0 Macrophage derived chemokine [Mass/volume] in Serum or Plasma by Immunoassay Macrophage derived chemokine MCnc Pt Ser/Plas Qn IA
2024-01-04 103785-2 Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) [Mass/volume] in Serum or Plasma by Immunoassay Monocyte Chemoattractant Proteins 4 (MCP-4/CCL13) MCnc Pt Ser/Plas Qn IA
2024-01-04 103784-5 Chemokine (C-C motif) ligand 26 [Mass/volume] in Serum or Plasma by Immunoassay Chemokine (C-C motif) ligand 26 MCnc Pt Ser/Plas Qn IA
2024-01-03 103782-9 PAINAD.Assessment interpretation Observed PAINAD.assessment interpretation Find Pt ^Patient Ord Observed
2024-01-03 103781-1 PAINAD.Total score Observed PAINAD.total score Score Pt ^Patient Qn Observed
2024-01-03 103780-3 PAINAD pain assessment panel PAINAD pain assessment panel - Pt ^Patient -
2024-01-03 103779-5 PAINAD.Body language Observed PAINAD.body language Find Pt ^Patient Ord Observed
2024-01-03 103778-7 PAINAD.Facial expression Observed PAINAD.facial expression Find Pt ^Patient Ord Observed
2024-01-03 103777-9 PAINAD.Negative vocalization Observed PAINAD.negative vocalization Find Pt ^Patient Ord Observed
2024-01-03 103776-1 PAINAD.Breathing Observed PAINAD.breathing Find Pt ^Patient Ord Observed
2024-01-03 103775-3 PAINAD.Consolability Observed PAINAD.consolability Find Pt ^Patient Ord Observed
2024-01-03 103774-6 We cannot trust science because it moves too slowly We cannot trust science because it moves too slowly Find Pt ^Patient Ord
2024-01-03 103773-8 Today's scientists will sacrifice the well-being of others to advance their research Today's scientists will sacrifice the well-being of others to advance their research Find Pt ^Patient Ord
2024-01-03 103772-0 Scientist will protect each other even when they are wrong Scientist will protect each other even when they are wrong Find Pt ^Patient Ord
2024-01-03 103771-2 We cannot trust scientists because they are biased in their perspectives We cannot trust scientists because they are biased in their perspectives Find Pt ^Patient Ord
2024-01-03 103770-4 I trust scientists can find solutions to our major technological problems I trust scientists can find solutions to our major technological problems Find Pt ^Patient Ord
2024-01-03 103768-8 We can trust science to find the answers that explain the natural world We can trust science to find the answers that explain the natural world Find Pt ^Patient Ord
2024-01-03 103767-0 People who understand science more have more trust in science People who understand science more have more trust in science Find Pt ^Patient Ord
2024-01-03 103766-2 We cannot trust scientists to consider ideas that contradict their own We cannot trust scientists to consider ideas that contradict their own Find Pt ^Patient Ord
2024-01-03 103765-4 When scientists form a hypothesis they are just guessing When scientists form a hypothesis they are just guessing Find Pt ^Patient Ord
2024-01-03 103764-7 Scientific theories are trustworthy Scientific theories are trustworthy Find Pt ^Patient Ord
2024-01-03 103763-9 We should trust that scientists are being ethical in their work We should trust that scientists are being ethical in their work Find Pt ^Patient Ord
2024-01-03 103762-1 We should trust that scientists are being honest in their work We should trust that scientists are being honest in their work Find Pt ^Patient Ord
2024-01-03 103761-3 We should trust the work of scientists We should trust the work of scientists Find Pt ^Patient Ord
2024-01-03 103760-5 Scientists don't care if laypersons understand their work Scientists don't care if laypersons understand their work Find Pt ^Patient Ord
2024-01-03 103759-7 I trust that the work of scientists to make life better for people I trust that the work of scientists to make life better for people Find Pt ^Patient Ord
2024-01-03 103758-9 Scientists don't value the ideas of others Scientists don't value the ideas of others Find Pt ^Patient Ord
2024-01-03 103757-1 We can trust scientists to share their discoveries even if they don't like their findings We can trust scientists to share their discoveries even if they don't like their findings Find Pt ^Patient Ord
2024-01-03 103756-3 Scientists intentionally keep their work secret Scientists intentionally keep their work secret Find Pt ^Patient Ord
2024-01-03 103755-5 Scientific theories are weak explanations Scientific theories are weak explanations Find Pt ^Patient Ord
2024-01-03 103754-8 Scientists ignore evidence that contradicts their work Scientists ignore evidence that contradicts their work Find Pt ^Patient Ord
2024-01-03 103753-0 When scientists change their mind about a scientific idea it diminishes my trust in their work When scientists change their mind about a scientific idea it diminishes my trust in their work Find Pt ^Patient Ord
2024-01-03 103752-2 In general do you think that most people can be trusted or that you can't be careful enough when dealing with other people In general do you think that most people can be trusted or that you can't be careful enough when dealing with other people Find Pt ^Patient Ord
2024-01-03 103751-4 Mental health Mental health directive form Mental health directive form Find Pt {Setting} Doc Mental health
2024-01-03 103750-6 Hemoglobin [Moles/volume] in Venous cord blood Hemoglobin SCnc Pt BldCoV Qn
2024-01-03 103749-8 Oxygen consumption (VO2) --peak Oxygen consumption^peak VRat Pt ^Patient Qn
2024-01-03 103748-0 Is the patient on non-invasive mechanical ventilation support Non-invasive mechanical ventilation support Find Pt ^Patient Ord
2024-01-03 103747-2 Is the patient on invasive mechanical ventilation support Invasive mechanical ventilation support Find Pt ^Patient Ord
2023-12-22 103746-4 Human papilloma virus 16 and 18+45 mRNA [Presence] in Anorectal by NAA with probe detection Human papilloma virus 16 & 18+45 mRNA PrThr Pt Anorectal Ord Probe.amp.tar
2023-12-22 103745-6 Time interval between troponin I.high-sensitivity assays Time interval between troponin I.high-sensitivity assays Time Pt ^Patient Qn
2023-12-22 103744-9 Other cells/100 leukocytes in Bronchoalveolar lavage by Manual count Other cells/100 leukocytes NFr Pt BAL Qn Manual count
2023-12-22 103743-1 Autoimmune lymphoproliferative syndrome multigene analysis in Specimen by Molecular genetics method Autoimmune lymphoproliferative syndrome multigene analysis Find Pt XXX Doc Molgen
2023-12-22 103742-3 Viral Susceptibility multigene analysis in Specimen by Molecular genetics method Viral Susceptibility multigene analysis Find Pt XXX Doc Molgen
2023-12-22 103741-5 Dysregulation autoimmune multigene analysis in Specimen by Molecular genetics method Dysregulation autoimmune multigene analysis Find Pt XXX Doc Molgen
2023-12-22 103740-7 Hyper igE syndrome multigene analysis in Specimen by Molecular genetics method Hyper igE syndrome multigene analysis Find Pt XXX Doc Molgen
2023-12-22 103739-9 EBV Lymphoproliferation multigene analysis in Blood or Tissue by Molecular genetics method EBV Lymphoproliferation multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103738-1 RBC membrane multigene analysis in Specimen by Sequencing RBC membrane multigene analysis Find Pt XXX Doc Sequencing
2023-12-22 103737-3 CYB5 and CYB5 Reductase multigene analysis in Specimen by Sequencing CYB5 and CYB5 Reductase multigene analysis Find Pt XXX Doc Sequencing
2023-12-22 103736-5 Erythrocytosis focused multigene analysis in Specimen by Sequencing Erythrocytosis focused multigene analysis Find Pt XXX Doc Sequencing
2023-12-22 103735-7 Erythrocytosis multigene analysis in Specimen by Sequencing Erythrocytosis multigene analysis Find Pt XXX Doc Sequencing
2023-12-22 103734-0 Dyserythropoietic anemia multigene analysis in Specimen by Sequencing Dyserythropoietic anemia multigene analysis Find Pt XXX Doc Sequencing
2023-12-22 103733-2 Hereditary emery dreifuss multigene analysis in Blood or Tissue by Molecular genetics method Hereditary emery dreifuss multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103732-4 Hereditary congenital myasthenic syndrome multigene analysis in Blood or Tissue by Molecular genetics method Hereditary congenital myasthenic syndrome multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103731-6 Distal weakness multigene analysis in Blood or Tissue by Molecular genetics method Distal weakness multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103730-8 Hereditary spastic paraplegia multigene analysis in Blood or Tissue by Molecular genetics method Hereditary spastic paraplegia multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103729-0 Hereditary sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method Hereditary sensory neuropathy multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103728-2 Hereditary motor and sensory neuropathy multigene analysis in Blood or Tissue by Molecular genetics method Hereditary motor and sensory neuropathy multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103727-4 Hereditary Motor Neuropathy multigene analysis in Blood or Tissue by Molecular genetics method Hereditary motor neuropathy multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-22 103726-6 Cells.chromosome region 20q12 deletion/Cells counted in Blood or Marrow by FISH Cells.chromosome region 20q12 deletion/Cells counted NFr Pt Bld/Bone mar Qn FISH
2023-12-21 103725-8 Suvorexant [Mass/volume] in Urine by LC/MS/MS Suvorexant MCnc Pt Urine Qn LC/MS/MS
2023-12-21 103724-1 Suvorexant [Presence] in Urine by LC/MS/MS Suvorexant PrThr Pt Urine Ord LC/MS/MS
2023-12-20 103723-3 Leishmania spp DNA [Presence] in Blood by NAA with non-probe detection Leishmania spp DNA PrThr Pt Bld Ord Non-probe.amp.tar
2023-12-20 103722-5 Yellow fever virus RNA [Presence] in Blood by NAA with non-probe detection Yellow fever virus RNA PrThr Pt Bld Ord Non-probe.amp.tar
2023-12-20 103721-7 West Nile virus RNA [Presence] in Blood by NAA with non-probe detection West Nile virus RNA PrThr Pt Bld Ord Non-probe.amp.tar
2023-12-20 103719-1 Lassa virus RNA [Presence] in Blood by NAA with non-probe detection Lassa virus RNA PrThr Pt Bld Ord Non-probe.amp.tar
2023-12-20 103718-3 Ebolavirus Bundibugyo+Reston+Sudan+Taï Forest+Zaire RNA [Presence] in Blood by NAA with non-probe detection Ebolavirus Bundibugyo+Reston+Sudan+Taï Forest+Zaire RNA PrThr Pt Bld Ord Non-probe.amp.tar
2023-12-20 103717-5 Crimean-Congo hemorrhagic fever virus RNA [Presence] in Blood by NAA with non-probe detection Crimean-Congo hemorrhagic fever virus RNA PrThr Pt Bld Ord Non-probe.amp.tar
2023-12-20 103716-7 Yersina pestis DNA [Presence] in Blood by NAA with non-probe detection Yersina pestis DNA PrThr Pt Bld Ord Non-probe.amp.tar
2023-12-20 103715-9 GABAAR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay Gamma aminobutyrate A receptor Ab.IgG PrThr Pt CSF Ord CBA IFA
2023-12-19 103714-2 Karyotype [Identifier] in Tissue from Fetus Narrative Karyotype Prid Pt Tiss^Fetus Nar
2023-12-19 103713-4 Cell growth [Presence] of Chorionic villus sample Qualitative by Tissue culture Cell growth PrThr Pt CVS Ord Tissue culture
2023-12-18 103712-6 Entamoeba hartmanni DNA [Presence] in Stool by NAA with probe detection Entamoeba hartmanni DNA PrThr Pt Stool Ord Probe.amp.tar
2023-12-18 103711-8 Nickel IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) Nickel Ab.IgE PrThr Pt Ser SemiQn RAST
2023-12-18 103710-0 Chenodeoxycholate+Cholate/Bile acid.total in Stool Chenodeoxycholate+Cholate/Bile acid.total SFr Pt Stool Qn
2023-12-15 103709-2 How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy during assessment period [CMS Assessment] How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy Find RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103708-4 Race during assessment period [CMS Assessment] Race Type RptPeriod ^Patient Nom CMS Assessment
2023-12-15 103707-6 Staff assessment of resident mood total severity score during assessment period [CMS Assessment] Staff assessment of resident mood total severity score Score RptPeriod ^Patient Qn CMS Assessment
2023-12-15 103706-8 Staff assessment of resident mood (PHQ-9-OV) during assessment period [CMS Assessment] Staff assessment of resident mood (PHQ-9-OV) - RptPeriod ^Patient - CMS Assessment
2023-12-15 103705-0 Mood interview total severity score during assessment period [CMS Assessment] Mood interview total severity score Score RptPeriod ^Patient Qn CMS Assessment
2023-12-15 103704-3 Brief Interview for Mental Status - summary score during assessment period [CMS Assessment] Brief interview for mental status - summary score Score RptPeriod ^Patient Qn CMS Assessment
2023-12-15 103703-5 Temporal orientation - current day of the week [CMS Assessment] Temporal orientation - current day of the week Find RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103702-7 Temporal orientation (orientation to year, month, and day) during assessment period [CMS Assessment] Temporal orientation (orientation to year, month, and day) - RptPeriod ^Patient - CMS Assessment
2023-12-15 103701-9 Recall - bed during assessment period [CMS Assessment] Recall - bed Find RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103700-1 Recall - blue during assessment period [CMS Assessment] Recall - blue Find RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103699-5 Recall - sock during assessment period [CMS Assessment] Recall - sock Find RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103698-7 Temporal orientation - current month during assessment period [CMS Assessment] Temporal orientation - current month Find RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103697-9 Temporal orientation - current year during assessment period [CMS Assessment] Temporal orientation - current year Find RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103696-1 Repetition of three words during assessment period [CMS Assessment] Repetition of three words Num RptPeriod ^Patient Ord CMS Assessment
2023-12-15 103695-3 Recall during assessment period [CMS Assessment] Recall - RptPeriod ^Patient - CMS Assessment
2023-12-15 103694-6 Brief interview for mental status during assessment period [CMS Assessment] Brief interview for mental status - RptPeriod ^Patient - CMS Assessment
2023-12-15 103693-8 Body weight during assessment period [CMS Assessment] Body weight Mass RptPeriod ^Patient Qn CMS Assessment
2023-12-15 103692-0 Body height during assessment period [CMS Assessment] Body height Len RptPeriod ^Patient Qn CMS Assessment
2023-12-13 103691-2 MDA5 Ab [Units/volume] in Serum by Immunoassay MDA5 Ab ACnc Pt Ser Qn IA
2023-12-13 103690-4 Fungal pathogens panel - Cerebral spinal fluid by NAA with probe detection Fungal Pathogens Panel - Pt CSF - Probe.amp.tar
2023-12-13 103689-6 Histoplasma sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection Histoplasma sp DNA PrThr Pt CSF Ord Probe.amp.tar
2023-12-13 103688-8 Blastomyces sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection Blastomyces sp DNA PrThr Pt CSF Ord Probe.amp.tar
2023-12-13 103687-0 Coccidioides sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection Coccidioides sp DNA PrThr Pt CSF Ord Probe.amp.tar
2023-12-13 103686-2 Pneumocystis jiroveci DNA [Presence] in Cerebral spinal fluid by NAA with probe detection Pneumocystis jiroveci DNA PrThr Pt CSF Ord Probe.amp.tar
2023-12-13 103685-4 Citalopram [Mass/volume] in Urine by LC/MS/MS Citalopram MCnc Pt Urine Qn LC/MS/MS
2023-12-13 103684-7 Vortioxetine [Presence] in Urine by LC/MS/MS Vortioxetine PrThr Pt Urine Ord LC/MS/MS
2023-12-12 103680-5 TP53 gene full mutation analysis in Blood or Tissue by Molecular genetics method TP53 gene full mutation analysis Find Pt Bld/Tiss Doc Molgen
2023-12-12 103678-9 CTNNB1 gene targeted mutation analysis in Tumor by Molecular genetics method CTNNB1 gene targeted mutation analysis Find Pt Tumor Doc Molgen
2023-12-12 103677-1 HMEP-Hemiplegic migraine multigene analysis in Blood or Tissue by Molecular genetics method Hemiplegic migraine multigene analysis Find Pt Bld/Tiss Doc Molgen
2023-12-12 103676-3 Soluble triggering receptor expressed on myeloid cells-1 [Mass/volume] in Serum or Plasma by Immunoassay Soluble triggering receptor expressed on myeloid cells-1 MCnc Pt Ser/Plas Qn IA
2023-12-12 103675-5 Phosphorylated tau 181 [Mass/volume] in Plasma by Immunoassay Tau protein.phosphorylated 181 MCnc Pt Plas Qn IA
2023-12-11 103674-8 Cells.chromosome region 1q21 duplication in Blood or Marrow by FISH Cells.chromosome region 1q21 duplication NFr Pt Bld/Bone mar Qn FISH
2023-12-11 103673-0 Isavuconazole [Susceptibility] in Isolate by Gradient strip Isavuconazole Susc Pt Isolate OrdQn Gradient strip
2023-12-11 103672-2 Amoxicillin+Clavulanate [Susceptibility] for UTI Amoxicillin+Clavulanate Susc Pt Isolate.UTI OrdQn
2023-12-11 103671-4 Mitragynine [Presence] in Cord tissue by Confirmatory method Mitragynine PrThr Pt TissCo Ord Confirm
2023-12-11 103670-6 Gabapentin [Presence] in Cord tissue by Confirmatory method Gabapentin PrThr Pt TissCo Ord Confirm
2023-12-11 103669-8 Mitragynine [Presence] in Cord tissue by Screen method Mitragynine PrThr Pt TissCo Ord Screen
2023-12-11 103668-0 Gabapentin [Presence] in Cord tissue by Screen method Gabapentin PrThr Pt TissCo Ord Screen
2023-12-11 103667-2 Cells.chromosome region 1p32 deletion/Cells counted in Blood or Marrow by FISH Cells.chromosome region 1p32 deletion/Cells counted NFr Pt Bld/Bone mar Qn FISH
2023-12-11 103666-4 Cells.CD200/100 cells in Bone marrow by Flow cytometry (FC) Cells.CD200/100 cells NFr Pt Bone marrow Qn Flow cytometry
2023-12-11 103665-6 CD4+ CD26- Cells/100 CD4 cells in Blood by Flow cytometry (FC) Cells.CD4+CD26-/100 cells.CD4 NFr Pt Bld Qn Flow cytometry
2023-12-11 103664-9 Dehydronorketamine [Mass/volume] in Urine by LC/MS/MS Dehydronorketamine MCnc Pt Urine Qn LC/MS/MS
2023-12-11 103663-1 Salmonella and Shigella and Campylobacter and E. coli sp identified in Stool by Organism specific culture Salmonella & Shigella & Campylobacter & E. coli sp identified Prid Pt Stool Nom Organism specific culture
2023-12-11 103662-3 Campylobacter and Salmonella and Shigella and Yersinia sp identified in Stool by Organism specific culture Campylobacter & Salmonella & Shigella & Yersinia sp identified Prid Pt Stool Nom Organism specific culture
2023-12-11 103661-5 Campylobacter and Salmonella and Shigella sp identified in Stool by Organism specific culture Campylobacter & Salmonella & Shigella sp identified Prid Pt Stool Nom Organism specific culture
2023-12-11 103660-7 Entamoeba coli DNA [Presence] in Stool by NAA with probe detection Entamoeba coli DNA PrThr Pt Stool Ord Probe.amp.tar
2023-12-11 103659-9 Cells.chromosome Y deletion/Cells counted in Blood or Marrow by FISH Cells.chromosome Y deletion/Cells counted NFr Pt Bld/Bone mar Qn FISH
2023-12-11 103657-3 Color of Spun Pericardial fluid Color Type Pt Pericard fld.spun Nom
2023-12-11 103656-5 Color of Spun Peritoneal fluid Color Type Pt Periton fld.spun Nom
2023-12-11 103655-7 Color of Spun Pleural fluid Color Type Pt Plr fld.spun Nom
2023-12-11 103654-0 Meropenem [Susceptibility] for meningitis Meropenem Susc Pt Isolate.meningitis OrdQn
2023-12-11 103653-2 Ciprofloxacin [Susceptibility] for meningitis Ciprofloxacin Susc Pt Isolate.meningitis OrdQn
2023-12-11 103652-4 4-Hydroxyatomoxetine [Mass/volume] in Urine by Confirmatory method 4-Hydroxyatomoxetine MCnc Pt Urine Qn Confirm
2023-12-11 103651-6 Atomoxetine [Presence] in Urine by Confirmatory method Atomoxetine PrThr Pt Urine Ord Confirm
2023-12-11 103650-8 Lutropin [Units/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone Lutropin^4H post dose gonadotropin releasing hormone ACnc Pt Ser/Plas Qn
2023-12-11 103649-0 Lutropin [Units/volume] in Serum or Plasma --10 minutes post dose gonadotropin releasing hormone Lutropin^10M post dose gonadotropin releasing hormone ACnc Pt Ser/Plas Qn
2023-12-11 103648-2 Follitropin [Units/volume] in Serum or Plasma --4 hours post dose gonadotropin releasing hormone Follitropin^4H post dose gonadotropin releasing hormone ACnc Pt Ser/Plas Qn
2023-12-11 103647-4 Cortisol [Mass/volume] in Serum or Plasma --2 hour post dose corticotropin Cortisol^2H post dose corticotropin MCnc Pt Ser/Plas Qn
2023-12-11 103646-6 clozapine N-oxide [Mass/volume] in Urine by Confirmatory method Clozapine N-oxide MCnc Pt Urine Qn Confirm
2023-12-11 103645-8 Asenapine [Mass/volume] in Urine by Confirmatory method Asenapine MCnc Pt Urine Qn Confirm
2023-12-11 103644-1 N-Desmethylasenapine [Mass/volume] in Urine by Confirmatory method N-Desmethylasenapine MCnc Pt Urine Qn Confirm
2023-12-11 103643-3 Iloperidone [Mass/volume] in Urine by Confirmatory method Iloperidone MCnc Pt Urine Qn Confirm
2023-12-11 103642-5 Herpes virus 6B DNA [Units/volume] (viral load) in Serum or Plasma by NAA with non-probe detection Herpes virus 6B DNA ACnc Pt Ser/Plas Qn Non-probe.amp.tar
2023-12-11 103641-7 Herpes virus 6A DNA [#/volume] (viral load) in Serum or Plasma by NAA with non-probe detection Herpes virus 6A DNA NCnc Pt Ser/Plas Qn Non-probe.amp.tar
2023-12-11 103640-9 4-hydroxy Xylazine/Creatinine [Mass Ratio] in Urine by Confirmatory method 4-hydroxy xylazine/Creatinine MRto Pt Urine Qn Confirm
2023-12-11 103639-1 4-hydroxy Xylazine [Presence] in Urine by Confirmatory method 4-hydroxy Xylazine PrThr Pt Urine Ord Confirm
2023-12-11 103638-3 4-hydroxy Xylazine [Mass/volume] in Urine by Confirmatory method 4-hydroxy Xylazine MCnc Pt Urine Qn Confirm
2023-12-11 103637-5 Atlantic wreckfish IgE Ab [Units/volume] in Serum Polyprion americanus Ab.IgE ACnc Pt Ser Qn
2023-12-11 103636-7 Atlantic wreckfish IgE Ab [Presence] in Serum by Radioallergosorbent test (RAST) Polyprion americanus Ab.IgE PrThr Pt Ser SemiQn RAST
2023-12-11 103635-9 Chromium IgE Ab [Units/volume] in Serum Chromium Ab.IgE ACnc Pt Ser Qn
2023-12-08 103634-2 Coccidioides sp IgG and IgM [Units/volume] in Serum and CSF Qualitative by Immunoassay Coccidioides sp Ab.IgG & IgM ACnc Pt Ser+CSF Ord IA
2023-12-08 103633-4 Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis [Presence] in Genital fluid by NAA with probe detection Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis PrThr Pt Genital fld Ord Probe.amp.tar
2023-12-07 103629-2 Monkeypox virus IgG Ab [Titer] in Serum by Immunoassay Monkeypox virus Ab.IgG Titr Pt Ser SemiQn IA
2023-12-07 103630-0 Monkeypox virus IgM Ab [Titer] in Serum by Immunoassay Monkeypox virus Ab.IgM Titr Pt Ser SemiQn IA
2023-12-07 103628-4 Monkeypox virus neutralizing antibody [Titer] in Serum by Immunoassay Monkeypox virus Ab.Neut Titr Pt Ser SemiQn IA
2023-12-07 103627-6 Streptococcus pyogenes DNA [Presence] in Specimen by NAA with probe detection Streptococcus pyogenes DNA PrThr Pt XXX Ord Probe.amp.tar
2023-12-07 103626-8 Mycobacterium ulcerans DNA [Presence] in Specimen by NAA with probe detection Mycobacterium ulcerans DNA PrThr Pt XXX Ord Probe.amp.tar
2023-12-07 103625-0 Mycobacterium marinum DNA [Presence] in Specimen by NAA with probe detection Mycobacterium marinum DNA PrThr Pt XXX Ord Probe.amp.tar
2023-12-07 103624-3 Klebsiella pneumoniae oxytoca DNA [Presence] in Specimen by NAA with probe detection Klebsiella pneumoniae oxytoca DNA PrThr Pt XXX Ord Probe.amp.tar
2023-12-07 103622-7 Enterobacter spp DNA [Presence] in Specimen by NAA with probe detection Enterobacter spp DNA PrThr Pt XXX Ord Probe.amp.tar
2023-12-07 103623-5 Enterococcus faecalis+Enterococcus faecium DNA [Presence] in Specimen by NAA with probe detection Enterococcus faecalis+Enterococcus faecium DNA PrThr Pt XXX Ord Probe.amp.tar
2023-12-07 103621-9 Small lymphocytic lymphoma chromosome deletions AndOr rearrangements in Blood or Tissue by FISH Small lymphocytic lymphoma chromosome deletions &or rearrangements Find Pt Bld/Tiss Doc FISH
2023-12-07 103620-1 Lupus anticoagulant aPTT screening panel - Platelet poor plasma by Coagulation assay Lupus anticoagulant aPTT screening panel - Pt PPP - Coag
2023-12-07 103619-3 Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma by Coagulation assay Coagulation surface induced.lupus sensitive.buffer (LA control) Time Pt PPP Qn Coag
2023-12-05 103618-5 Hepatitis B virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection Hepatitis B virus RNA NCnc Pt Ser/Plas Qn Probe.amp.tar
2023-12-05 103617-7 Helicobacter pylori IgG Ab [Presence] in Blood by Immunoassay Helicobacter pylori Ab.IgG PrThr Pt Bld Ord IA
2023-12-05 103616-9 Creatinine [Moles/volume] in Serum or Plasma by LC/MS/MS Creatinine SCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103615-1 Erlotinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose Erlotinib^24H post dose MCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103613-6 Sunitinib total [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose Sunitinib.total^24H post dose MCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103614-4 Gefitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose Gefitinib^24H post dose MCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103612-8 N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose N-Desethyl Sunitinib^24H post dose MCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103611-0 Sunitinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose Sunitinib^24H post dose MCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103610-2 Pazopanib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose Pazopanib^24H post dose MCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103609-4 Imatinib [Mass/volume] in Serum or Plasma by LC/MS/MS --24 hours post dose Imatinib ^24H post dose MCnc Pt Ser/Plas Qn LC/MS/MS
2023-12-01 103608-6 Sulbactam+Durlobactam [Susceptibility] by Gradient strip Sulbactam+Durlobactam Susc Pt Isolate OrdQn Gradient strip
2023-11-30 103607-8 Paroxetine metabolite III [Mass/volume] in Urine by Confirmatory method Paroxetine metabolite III MCnc Pt Urine Qn Confirm
2023-11-30 103606-0 Paroxetine M-II [Mass/volume] in Urine by Confirmatory method Paroxetine metabolite II MCnc Pt Urine Qn Confirm
2023-11-30 103605-2 Paroxetine metabolite I [Mass/volume] in Urine by Confirmatory method Paroxetine metabolite I MCnc Pt Urine Qn Confirm
2023-11-30 103604-5 Carbamazepine 10,11-Epoxide [Mass/volume] in Urine carBAMazepine 10,11-Epoxide MCnc Pt Urine Qn
2023-11-30 103603-7 Tick-borne Ab panel [Titer] - Serum Tick-borne Ab panel Titr Pt Ser SemiQn
2023-11-30 103602-9 6-Hydroxychlorzoxazone [Mass/volume] in Urine 6-Hydroxychlorzoxazone MCnc Pt Urine Qn
2023-11-30 103601-1 Staphylococcus aureus MLVA type in Isolate or Specimen by Molecular genetics method Staphylococcus aureus MLVA type Type Pt Isolate/Specimen Nom Molgen
2023-11-30 103600-3 Baclofen [Mass/volume] in Urine by LC/MS/MS Baclofen MCnc Pt Urine Qn LC/MS/MS
2023-11-22 103599-7 Reason for discharge from the intensive care unit Reason for discharge Find Pt ^Patient Nom
2023-11-13 103598-9 Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells from Fetus Direct antiglobulin test.polyspecific reagent PrThr Pt RBC^Fetus Ord
2023-11-10 103597-1 Pain management form or template Pain management form or template Find Pt ^Patient Doc
2023-11-10 103596-3 Durable medical equipment proof of delivery receipt Durable medical equipment proof of delivery receipt Find Pt ^Patient Doc
2023-11-10 103595-5 Certificate of Medical Necessity Certificate of medical necessity Find Pt ^Patient Doc
2023-11-09 103594-8 Acetyl norfentanyl [Mass/volume] in Cord tissue by Confirmatory method Acetyl norfentanyl MCnc Pt TissCo Qn Confirm
2023-11-09 103593-0 Cell growth [Presence] of Amniocytes Qualitative by Tissue culture Cell growth PrThr Pt Amniocytes Ord Tissue culture
2023-11-07 103592-2 Retinal eye screening report Document Retinal eye screening report Find Pt ^Patient Doc
2023-11-07 103591-4 Comprehensive foot screening report Document Comprehensive foot screening report Find Pt ^Patient Doc
2023-11-07 103590-6 Bacterial vaginosis RNA [Presence] in Vagina by Probe with amplification Bacterial vaginosis RNA PrThr Pt Vagina Ord Probe.amp
2023-11-06 103589-8 Flualprazolam [Presence] in Cord tissue by Confirmatory method Flualprazolam PrThr Pt TissCo Ord Confirm
2023-11-06 103588-0 Etizolam [Presence] in Cord tissue by Confirmatory method Etizolam PrThr Pt TissCo Ord Confirm
2023-11-06 103577-3 Albumin [Mass/volume] in Serum by Immunoassay Albumin MCnc Pt Ser Qn IA
2023-11-06 103576-5 Horse dander IgE panel - Serum or Plasma Horse dander Ab.IgE panel - Pt Ser/Plas -
2023-11-06 103575-7 Cat epithelium IgE panel - Serum or Plasma Cat epithelium Ab.IgE panel - Pt Ser/Plas -
2023-11-06 103574-0 Dog dander IgE panel - Serum or Plasma Dog dander Ab.IgE panel - Pt Ser/Plas -
2023-11-06 103573-2 FDA package insert Cosmetic facility registration Cosmetic facility registration Find Pt ^FDA package insert Nar
2023-11-06 103572-4 FDA package insert Cosmetic product listing Cosmetic product listing Find Pt ^FDA package insert Nar
2023-11-06 103571-6 Study observation Ocular fundus Angiography W fluorescein IV Study observation^W fluorescein IV Find Pt Ocular fundus Nom Angiography
2023-11-06 103570-8 AAV serotype rh74 Ab [Presence] in Serum or Plasma by Immunoassay AAV serotype rh74 Ab PrThr Pt Ser/Plas Ord IA
2023-11-03 103568-2 MDS v3.0 - RAI v1.19.1 - COVID-19 Vaccine [CMS Assessment] COVID-19 Vaccine - RptPeriod ^Patient - CMS Assessment
2023-11-03 103567-4 FHIR previous cancer therapy medical record FHIR previous cancer therapy medical record Find Pt {Setting} Doc
2023-11-03 103566-6 Metagenomic DNA and RNA Sequencing Metagenomic DNA and RNA Sequencing Prid Pt CSF Nom Sequencing
2023-11-02 103565-8 HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA+Hepatitis E virus RNA PrThr Pt Ser/Plas/Bld^Donor Ord Probe.amp.tar
2023-10-25 103562-5 AB-Fubinaca metabolite 3 [Mass/volume] in Urine by Confirmatory method AB-Fubinaca metabolite 3 MCnc Pt Urine Qn Confirm
2023-10-24 103560-9 Aldosterone/Renin [Ratio] in Serum or Plasma Aldosterone/Renin Ratio Pt Ser/Plas Qn
2023-09-28 103558-3 NR4A3 gene rearrangements in Blood or Tissue by FISH NR4A3 gene rearrangements Find Pt Bld/Tiss Doc FISH
2023-08-23 103556-7 PLA2G7 and PLAC8 gene expression level [Score] in Blood by Molecular genetics method PLA2G7 & PLAC8 gene expression level Score Pt Bld Qn Molgen
2023-08-15 103555-9 Escherichia coli O157:H7 DNA [Presence] in Wound by NAA with probe detection Escherichia coli O157:H7 DNA PrThr Pt Wound Ord Probe.amp.tar
2023-08-04 103554-2 Surgical oncology Progress note Progress note Find Pt {Setting} Doc Surgical oncology
2023-08-04 103553-4 Psychology Summary note Summary note Find Pt {Setting} Doc Psychology
2023-08-04 103552-6 Psychology Annual evaluation note Annual evaluation note Find Pt {Setting} Doc Psychology
2023-08-04 103551-8 Brain injury Outpatient Note Note Find Pt Outpatient Doc Brain injury
2023-08-04 103550-0 Physical therapy Outpatient Evaluation note Evaluation note Find Pt Outpatient Doc Physical therapy
2023-08-04 103549-2 Gastroenterology Outpatient Consult note Consultation note Find Pt Outpatient Doc Gastroenterology
2023-08-04 103548-4 Obstetrics Midwife Progress note Progress note Find Pt {Setting} Doc Obstetrics.midwife
2023-08-04 103547-6 Trauma Referral note Referral note Find Pt {Setting} Doc Trauma
2023-08-04 103546-8 General medicine Preoperative evaluation and management note Preoperative evaluation and management note Find Pt {Setting} Doc General medicine
2023-08-04 103545-0 Physical medicine and rehab Outpatient Consult note Consultation note Find Pt Outpatient Doc Physical medicine and rehab
2023-08-04 103544-3 Clinical cardiac electrophysiology Surgical operation note Surgical operation note Find Pt {Setting} Doc Clinical cardiac electrophysiology
2023-08-04 103543-5 Rapid response team History and physical note History and physical note Find Pt {Setting} Doc Rapid response team
2023-06-30 102109-6 Oxalate and Glycolate and Glyoxylate and Citrate [Interpretation] in Urine Oxalate & Glycolate & Glyoxylate & Citrate Imp Pt Urine Nom
2023-06-30 102108-8 Glycerate [Moles/volume] in Urine by Gas chromatography-mass spectrometry Glycerate SCnc Pt Urine Qn GC-MS
2023-06-30 102093-2 HLA-ABDR typing panel - Blood or Tissue from Donor HLA-ABDR typing panel - Pt Bld/Tiss^Donor -
2023-06-30 102092-4 HLA-ABDR typing panel - Blood or Tissue HLA-ABDR typing panel - Pt Bld/Tiss -

TIP Click on headings to sort table by that column. Hold down Shift and click additional headings to add to sorting.

TIP In your web browser, use ControlF (or F on Mac) to find text on this page.

Receive notices of new and revised Special Use prerelease codes

Sign up to receive an email notification when new prerelease Special Use LOINC terms are created or revised.

For timely updates, follow @LOINC on Twitter. An RSS feed of new Special Use terms is also available.

  • Your information will only be used for the purposes of this notification and not disclosed to third parties.